Publications

2024

Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency survey.

Wespi N, Vavricka S, Brand S, Aepli P, Burri E, Misselwitz B, Seibold F, Hruz P, Peyrin-Biroulet L, Schoepfer A, Biedermann L, Sokollik C, Rogler G, Greuter T

United European Gastroenterol J. 2024 Sep 8

[Fontan associated liver disease].

Shams T, Salvador Nunes L, Schmidt S, Gast E, Sempoux C, Moradpour D, Di Bernardo S, Sekarski N, Rutz T, Ladouceur M, Bouchardy-Clément J, Coukos A, Fraga M

Rev Med Suisse. 2024 Aug 28;20(884):1469-1475

[Therapeutic endoscopic ultrasound: an innovative technique, revolutionizing our practice].

Robert-Dubois M, Godat S, Oumrani S, Romailler É, Dalex M, Marx M

Rev Med Suisse. 2024 Aug 28;20(884):1450-1455

[Gastroesophageal reflux disease in 2024].

Dalex M, Schoepfer AM, Wakim El-Khoury J

Rev Med Suisse. 2024 Aug 28;20(884):1464-1468

Cancer du pancréas : une épidémie oncologique en devenir ?

Frossard JL, Moradpour D

Rev Med Suisse. 2024 Aug 28;20(884):1439-1440

Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020.

Favre-Bulle T, Moradpour D, Marques-Vidal P, Vaucher J

BMJ Open. 2024 Aug 24;14(8):e081822

Odynophagia and Retrosternal Pain Are Common in Eosinophilic Esophagitis and Associated with an Increased Overall Symptom Severity.

Karpf J, Safroneeva E, Rossel JB, Hildenbrand F, Saner C, Greuter T, Rogler G, Straumann A, Schoepfer A, Biedermann L, Murray FR, Schreiner P

Dig Dis Sci. 2024 Aug 8

High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorder.

Coukos A, Saglietti C, Sempoux C, Haubitz M, Greuter T, Mittaz-Crettol L, Maurer F, Mdawar-Bailly E, Moradpour D, Alberio L, Good JM, Baerlocher GM, Fraga M

Hepatol Commun. 2024 Aug 1;8(8)

EUS-guided hepaticojejunostomy in patients with history of total gastrectomy: a multicenter retrospective feasibility study (with video).

Balducci D, Ratone JP, Schaefer M, Godat S, Perez-Cuadrado-Robles E, Hoibian S, Dahel Y, Dalex M, Chevaux JB, Caillol F, Giovannini M

Gastrointest Endosc. 2024 Jul 20

Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.

Radu P, Becchetti C, Schropp J, Schmid P, Künzler-Heule P, Mertens J, Moradpour D, Müllaupt B, Semela D, Negro F, Heim M, Clerc O, Roelens M, Keiser O, Berzigotti A, Swiss Hepatitis C Cohort Study

Cancers (Basel). 2024 Jul 18;16(14)

Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

El-Khoury JW, Safroneeva E, Saner C, Rossel JB, Trelle S, Zwahlen M, Biedermann L, Kreienbuehl A, Greuter T, Schreiner P, Netzer P, Franke A, Brand S, Hasler C, Aepli P, Burri E, Weber A, Sempoux C, Biral R, Jochum W, Diebold J, Willi N, Straumann A, Schoepfer AM, Swiss EoE Cohort Study Group

Inflamm Intest Dis. 2024 Jan-Dec;9(1):165-173

Simultaneous combined transplantation: Intricacies in immunosuppression management.

Del Bello A, Vionnet J, Congy-Jolivet N, Kamar N

Transplant Rev (Orlando). 2024 Jul 14;38(4):100871

[Colorectal cancer in 45-49-year-olds: systematic or targeted screening?].

Brändle K, Ducros C, Diserens C, Berger C, Godat S, Bulliard JL

Rev Med Suisse. 2024 Jul 3;20(881):1309-1313

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Müllhaupt B, Meier MA, Bernsmeier C, Ongaro M, Negro F, Grosjean M, Clerc O, Künzler-Heule P, Semela D, Hobi G, Stickel F, Mathieu A, Mdawar-Bailly E, Faouzi M, Moradpour D, Fraga M

Swiss Med Wkly. 2024 Jun 24;154(6):3698

Long-Term Outcome of Surgery for Perianal Crohn's Fistula.

Schaad M, Schoepfer A, Rossel JB, Barry MP, Rogler G, Hahnloser D, Swiss IBD Cohort Study Group

Medicina (Kaunas). 2024 Jun 24;60(7)

Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.

Xu ZM, Gnouamozi GE, Rüeger S, Shea PR, Buti M, Chan HL, Marcellin P, Lawless D, Naret O, Zeller M, Schneuing A, Scheck A, Junier T, Moradpour D, Podlaha O, Suri V, Gaggar A, Subramanian M, Correia B, Gfeller D, Urban S, Fellay J

Am J Hum Genet. 2024 Jun 6;111(6):1018-1034

Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis.

Gueguen E, Morsy Y, Mamie C, Schoepfer A, Saner C, Biedermann L, Straumann A, Kreienbühl A, Swiss EoE Cohort Study Group, Scharl M, Wawrzyniak M

Gut. 2024 Jun 6;73(7):1076-1086

A Hepatitis E Virus Infection Model in the Mongolian Gerbil: Ready for Antiviral and Vaccine Studies.

Gouttenoire J, Neyts J

Gastroenterology. 2024 May 23

Direct oral anticoagulants in cirrhosis: Rationale and current evidence.

Pereira Portela C, Gautier LA, Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Veuthey L, De Gottardi A, Stirnimann G, Alberio L

JHEP Rep. 2024 Aug;6(8):101116

Functional results after hiatal repair and gastropexy without fundoplication in patients with paraoesophageal hernia.

Bomio-Pacciorini L, Gaspar-Figueiredo S, Mantziari S, Godat S, Schäfer M, Teixeira Farinha H

Langenbecks Arch Surg. 2024 May 3;409(1):150

Endoscopic Features of Eosinophilic Esophagitis.

Schoepfer AM, Safroneeva E, Peterson K

Immunol Allergy Clin North Am. 2024 May;44(2):197-204

A false positive hair ethylglucuronide dosage in an alcohol abstinent patient after liver transplantation: a case report.

Favrod-Coune T, Lidsky D, Vionnet J, Magini G, Déglon J, Broers B

Front Med (Lausanne). 2024;11:1363012

Influence of Amino Acid Substitutions in Capsid Proteins of Coxsackievirus B5 on Free Chlorine and Thermal Inactivation.

Torii S, Gouttenoire J, Kumar K, Antanasijevic A, Kohn T

Environ Sci Technol. 2024 Mar 26;58(12):5279-5289

EUS-BD for calibration of benign stenosis of the bile duct in patients with altered anatomy or inaccessible papilla.

Caillol F, Godat S, Solovyev A, Harouchi A, Oumrani S, Marx M, Hoibian S, Dahel Y, Ratone JP, Giovannini M

Endosc Int Open. 2024 Mar;12(3):E377-E384

A MULTICENTER LONG-TERM COHORT STUDY OF EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR PROGRESSION TO EOE OVER TIME.

Greuter T, Straumann A, Fernandez-Marrero Y, Germic N, Hosseini A, Chanwangpong A, Yousefi S, Simon D, Collins MH, Bussmann C, Chehade M, Dellon ES, Furuta GT, Gonsalves N, Hirano I, Moawad FJ, Biedermann L, Safroneeva E, Schoepfer AM, Simon HU

Clin Transl Gastroenterol. 2024 Feb 6

Maladies inflammatoires chroniques de l’intestin chez les personnes âgées.

Michetti P

Rev Med Suisse. 2024 Jan 24;20(858):180-181

[Gastroenterology and hepatology: what's new in 2023].

Fraga M, Wakim El-Khoury J, Oumrani S, Godat S, Vionnet J, Schoepfer A, Vieira Barbosa J

Rev Med Suisse. 2024 Jan 17;20(856-7):42-46

Pediatric Patients with Eosinophilic Esophagitis and Their Parents Identify Symptoms as the Most Important Treatment Outcome.

von Graffenried T, Safroneeva E, Braegger C, Ezri J, Garzoni L, Giroud Rivier A, Greuter T, Köhler H, McLin VA, Marx G, Müller P, Petit LM, Schibli S, Sokollik C, Tempia-Caliera M, Zwahlen M, Schoepfer AM, Nydegger A

Int Arch Allergy Immunol. 2024;185(6):527-535

2023

A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication.

Oechslin N, Da Silva N, Ankavay M, Moradpour D, Gouttenoire J

Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2307423120

Eosinophil Distribution in Eosinophilic Esophagitis and its Impact on Disease Activity and Response to Treatment.

Godat A, Mueller R, Schenker D, Schoepfer AM, Straumann A, Greuter T, EoE Eosinophil Distribution Research Group

Clin Gastroenterol Hepatol. 2023 Dec 16

Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E.

Saadat A, Gouttenoire J, Ripellino P, Semela D, Amar S, Frey BM, Fontana S, Mdawar-Bailly E, Moradpour D, Fellay J, Fraga M, HEV Human Genetics Collaborators

Hepatology. 2023 Dec 8

A tridimensional atlas of the developing human head.

Blain R, Couly G, Shotar E, Blévinal J, Toupin M, Favre A, Abjaghou A, Inoue M, Hernández-Garzón E, Clarençon F, Chalmel F, Mazaud-Guittot S, Giacobini P, Gitton Y, Chédotal A

Cell. 2023 Dec 5

Endoscopic ultrasound-guided modification of surgical anatomy (from Roux-en-Y gastrectomy to Billroth II-like anatomy) for endoscopic treatment of malignant biliary stenosis.

Piazza G, Lázaro-Fontanet E, Cotton A, Godat S, Galasso D

Endoscopy. 2023 Dec;55(S 01):E827-E828

Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology.

Wiegand N, Geyer M, Lollo G, Wuillemin WA, Aepli P, Frei R, Godat S, Manz M, Seewald S, The FO, Wiest R, Borovicka J, Brand S, Buyse S, Degen L, Ehmann T, Riniker F, Riva D, Semela D, Truninger K, Utzinger E, Vonlaufen A

Praxis (Bern 1994). 2023 Dec;112(13):635-641

The high resolution absorption spectrum of methane in the 10 800-14 000 cm(-1) region: literature review, new results and perspectives.

Campargue A, Karlovets EV, Vasilchenko SS, Turbet M

Phys Chem Chem Phys. 2023 Dec 1

First report of Xanthomonas campestris pv. campestris causing black rot on oilseed rape (Brassica napus L.) in France.

Cesbron S, Briand M, Dittmer J, Bousset-Vaslin L, Jacques MA, Sarniguet A

Plant Dis. 2023 Nov 30

High-Pressure Delivery of Oncolytic Viruses via Needle-Free Injection Preserves Therapeutic Activity.

Said A, Hoang HD, Earl N, Xiang X, Siddiqui N, Côté M, Alain T

Cancers (Basel). 2023 Nov 30;15(23)

Anti-CMV therapy, what next? A systematic review.

Gourin C, Alain S, Hantz S

Front Microbiol. 2023;14:1321116

Conditional knockout of REST/NRSF in excitatory neurons reduces seizure susceptibility to chemical kindling.

Natali G, Michetti C, Krawczun-Rygmaczewska A, Floss T, Cesca F, Benfenati F

Front Cell Neurosci. 2023;17:1267609

Neural alpha oscillations index context-driven perception of ambiguous vowel sequences.

Alain C, Göke K, Shen D, Bidelman GM, Bernstein LJ, Snyder JS

iScience. 2023 Dec 15;26(12):108457

Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.

Marx M, Caillol F, Godat S, Poizat F, Oumrani S, Ratone JP, Hoibian S, Dahel Y, Oziel-Taieb S, Niccoli P, Ewald J, Mitry E, Giovannini M

Ann Gastroenterol. 2023 Nov-Dec;36(6):686-693

Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis.

Appenzeller-Herzog C, Rosat A, Mathes T, Baroja-Mazo A, Chruscinski A, Feng S, Herrero I, Londono MC, Mazariegos G, Ohe H, Pons JA, Sanchez-Fueyo A, Waki K, Vionnet J

Liver Int. 2023 Oct 31

Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.

Heil A, Kuehlewindt T, Godat A, Simon HU, Simon D, Schreiner P, Saner C, Vavricka SR, Biedermann L, Safroneeva E, Rossel JB, Limacher A, Straumann A, Schoepfer AM, Greuter T

Int Arch Allergy Immunol. 2023 Oct 20:1-10

La maladie de Crohn.

Fitaire C, Michetti P

Rev Med Suisse. 2023 Sep 27;19(843):1761

Elevated liver function tests in a patient with breast cancer.

Neftel C, Zaman K, Chtioui H, Moradpour D, Sempoux C, Fraga M

J Hepatol. 2023 Sep;79(3):e109-e111

[siRNA therapeutics : Current options and perspectives].

Neftel C, Moradpour D

Rev Med Suisse. 2023 Aug 30;19(839):1538-1542

[Functional dyspepsia : update 2023].

Voirol-Perrin J, Stamm GM, Salvador Nunes L, Schoepfer A

Rev Med Suisse. 2023 Aug 30;19(839):1554-1557

Hépatologie en 2023 : importance de la multidisciplinarité.

Fraga M, Spahr L

Rev Med Suisse. 2023 Aug 30;19(839):1535-1536

[Management of dysphagia].

Caloz E, Tripet R, Marx M, Oumrani S, Ghaoui C, Wakim El-Khoury J, Godat S, Robert M

Rev Med Suisse. 2023 Aug 30;19(839):1548-1553

Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.

Rossier L, Matter C, Burri E, Galperine T, Hrúz P, Juillerat P, Schoepfer A, Vavricka SR, Zahnd N, Décosterd N, Seibold F

Swiss Med Wkly. 2023 Aug 25;153:40100

An Unusual Cause of Severe Granulomatous Hepatitis and Jaundice.

Coukos A, Uldry E, Meylan S, Schmidt S, Fasquelle F, Sempoux C, Fraga M

Am J Gastroenterol. 2023 Jul 10

[Management of acute cholecystitis].

Rrupa D, Robert-Dubois M, Uldry E, Demartines N, Halkic N, Godat S, Melloul E

Rev Med Suisse. 2023 Jun 14;19(831):1175-1179

Towards antivirals against hepatitis E: In the steps of hepatitis C.

Gouttenoire J, Neyts J

Hepatology. 2023 Jun 12

The current and future burden of hepatitis B in Switzerland: a modelling study.

Negro F, Müllhaupt B, Semela D, Blach S, Bruggmann P, De Gottardi A, Dufour JF, Fraga M, Galante A, Razavi H, Vieira Barbosa J, Razavi-Shearer D

Swiss Med Wkly. 2023 Jun 5;153:40086

Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Scherer R, Schreiner P, Rossel JB, Greuter T, Burri E, Saner C, Schlag C, Safroneeva E, Schoepfer A, Straumann A, Biedermann L

Dig Dis. 2023 May 24

Urine: a place where HEV cannot hide!

Behrendt P, Gouttenoire J

Hepatology. 2023 May 1;77(5):1475-1477

Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure.

Mangana Del Rio T, Sacleux SC, Vionnet J, Ichaï P, Denys A, Schneider A, Coilly A, Fraga M, Wetzel A, Koerfer J, Chiche JD, Saliba F, Moradpour D, Becce F, Artru F

JHEP Rep. 2023 Aug;5(8):100758

Efficacy and safety of endoscopic ultrasound guided drainage of pseudocysts and walled-off necrosis after failure of percutaneous drainage.

Mack S, Galasso D, Marx M, Robert M, Romailler E, Oumrani SH, Aslan N, Moschouri E, Schoepfer A, Godat S

Surg Endosc. 2023 Apr;37(4):2626-2632

[Frequent Gastro-Intestinal Disorders: Management of Functional Dyspepsia and Irritable Bowel Syndrome in Clinical Practice].

Pohl D, Vavricka S, Fox M, Madisch A, Studerus D, Wiesel P, Heinrich H, Linas I, Schoepfer A, Schwizer A, Wildi S

Praxis (Bern 1994). 2023 Apr;112(5-6):304-316

Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes.

Oechslin N, Ankavay M, Moradpour D, Gouttenoire J

Viruses. 2023 Mar 28;15(4)

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study.

Lautenschlager SA, Barry MP, Rogler G, Biedermann L, Schreiner P, Siebenhüner AR, Swiss IBD Cohort Study Group

BMC Gastroenterol. 2023 Mar 12;23(1):71

Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.

Coukos A, Vionnet J, Sempoux C, Fraga M

J Immunother Cancer. 2023 Feb;11(2)

External validation and comparison of the Glasgow-Blatchford score, modified Glasgow-Blatchford score, Rockall score and AIMS65 score in patients with upper gastrointestinal bleeding: a cross-sectional observational study in Western Switzerland.

Rivieri S, Carron PN, Schoepfer A, Ageron FX

Eur J Emerg Med. 2023 Feb 1;30(1):32-39

[Gastroenterology and hepatology: what's new in 2022].

Fraga M, Ghaoui C, Stamm GM, Schoepfer A, Greuter T

Rev Med Suisse. 2023 Feb 1;19(812):217-220

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.

Martinho-Grueber M, Kapoglou I, Bravo F, Sarraj R, Benz E, Restellini S, Biedermann L, Rogler G, Vavricka SR, Schoepfer A, Maillard MH, Michetti P, Brunner F, Clair C, Barry MP, Pittet V, von Känel R, Juillerat P

Eur J Gastroenterol Hepatol. 2023 Jan 1;35(1):21-30

Immunohistochemistry for hepatitis E virus capsid protein cross-reacts with cytomegalovirus-infected cells: a potential diagnostic pitfall.

Lenggenhager D, Grossmann J, Gouttenoire J, Sempoux C, Weber A

Histopathology. 2023 Jan;82(2):354-358

Marked weight loss on liraglutide 3.0 mg: Real-life experience of a Swiss cohort with obesity.

Santini S, Vionnet N, Pasquier J, Gonzalez-Rodriguez E, Fraga M, Pitteloud N, Favre L

Obesity (Silver Spring). 2023 Jan;31(1):74-82

2022

Drug-Related Adverse Events Necessitating Treatment Discontinuation in Pediatric Inflammatory Bowel Disease Patients.

Salzmann M, von Graffenried T, Righini-Grunder F, Braegger C, Spalinger J, Schibli S, Schoepfer A, Nydegger A, Pittet V, Sokollik C, Swiss IBD Cohort Study Group

J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):731-736

The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients.

Jordi SBU, Lang BM, Wyss J, Auschra B, Yilmaz B, Krupka N, Greuter T, Schreiner P, Biedermann L, Preisig M, von Känel R, Rogler G, Begré S, Misselwitz B, Swiss IBD cohort study group

J Gastroenterol. 2022 Nov;57(11):848-866

Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference.

Aceves SS, Alexander JA, Baron TH, Bredenoord AJ, Day L, Dellon ES, Falk GW, Furuta GT, Gonsalves N, Hirano I, Konda VJA, Lucendo AJ, Moawad F, Peterson KA, Putnam PE, Richter J, Schoepfer AM, Straumann A, McBride DL, Sharma P, Katzka DA

Gastrointest Endosc. 2022 Oct;96(4):576-592.e1

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.

Coukos A, Vionnet J, Obeid M, Bouchaab H, Peters S, Latifyan S, Wicky A, Michielin O, Chtioui H, Moradpour D, Fasquelle F, Sempoux C, Fraga M

J Immunother Cancer. 2022 Oct;10(10)

Hepatitis B reactivation during ruxolitinib treatment.

Sjoblom M, Chtioui H, Fraga M, Stalder G, Grandoni F, Blum S

Ann Hematol. 2022 Sep;101(9):2081-2086

La résection endoscopique va-t-elle suppléer la chirugie ?

Frossard JL, Moradpour D

Rev Med Suisse. 2022 Aug 31;18(793):1575-1576

[Differential diagnosis and investigation of chronic diarrhea].

Stamm GM, Salvador Nunes L, Greuter T, Godat S, Schoepfer A

Rev Med Suisse. 2022 Aug 31;18(793):1578-1583

[Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology].

Bianchetti D, Salvador Nunes L, André P, Schoepfer A, Moradpour D, Chtioui H

Rev Med Suisse. 2022 Aug 31;18(793):1588-1593

[Short telomere syndrome in adults: a rare entity that should be evoked].

Coukos A, Daccord C, Lazor R, Blum S, Naveiras O, Unger S, Vionnet J, Gaide O, Koutsokera A, Moschouri E, Sempoux C, Good JM, Moradpour D, Baerlocher GM, Fraga M

Rev Med Suisse. 2022 Aug 31;18(793):1606-1613

Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic Esophagitis.

Schreiner P, Safroneeva E, Rossel JB, Limacher A, Saner C, Greuter T, Schoepfer A, Straumann A, Biedermann L

Clin Gastroenterol Hepatol. 2022 Aug;20(8):1729-1738.e1

A novel case of biliary common bile duct reconstruction by the rendezvous technique using endoscopic cholangioscopy and percutaneous cholangioscopy.

Ratone JP, Caillol F, Marx M, Hoibian S, Dahel Y, Giovannini M, Devière J

Endoscopy. 2022 Jul 21

Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.

Tonneau M, Nolin-Lapalme A, Kazandjian S, Auclin E, Panasci J, Benlaifaoui M, Ponce M, Al-Saleh A, Belkaid W, Naimi S, Mihalcioiu C, Watson I, Bouin M, Miller W, Hudson M, Wong MK, Pezo RC, Turcotte S, Bélanger K, Jamal R, Oster P, Velin D, Richard C, Mes

Oncoimmunology. 2022;11(1):2096535

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.

Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK,

Gastroenterology. 2022 Jul;163(1):59-76

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.

J Allergy Clin Immunol. 2022 Jul;150(1):33-47

Reply to the letter to the editor.

Caillol F, Godat S, Giovannini M

Dig Endosc. 2022 Jun 22

Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.

Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM, Posovszky C, Rodrigues A, Russell RK, Barakat F, Auth MKH, Heuschkel R, Zilbauer M, Fyderek K, Braegger C, Travis SP, Satsangi J, Parkes M, Thapar N, Ferry H, Ma

Nat Commun. 2022 Jun 22;13(1):3576

EUS-guided hepaticogastrostomy in the management of malignant biliary obstruction: Experience and learning curve in a tertiary referral center.

Marx M, Caillol F, Sfumato P, Romero J, Ratone JP, Pesenti C, Godat S, Hoibian S, Dahel Y, Boher JM, Giovannini M

Dig Liver Dis. 2022 Jun 7

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma.

Greuter M, Eertink JJ, Jongeneel G, Dührsen U, Hüttmann A, Schmitz C, Lugtenburg PJ, Barrington SF, Mikhaeel NG, Ceriani L, Zucca E, Carr R, Györke T, Burggraaff CN, de Vet H, Hoekstra OS, Zijlstra JM, Coupé V, PETRA consortium.

Clin Lymphoma Myeloma Leuk. 2022 Jun;22(6):382-392

Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis.

Ma C, Bredenoord AJ, Dellon ES, Alexander JA, Biedermann L, Hogan M, Guizzetti L, Zou G, Katzka DA, Chehade M, Falk GW, Furuta GT, Gupta SK, Kagalwalla AF, Schoepfer AM, Miehlke S, Moawad FJ, Peterson K, Gonsalves NP, Straumann A, Wechsler JB, Rémillard J

Gastrointest Endosc. 2022 Jun;95(6):1126-1137.e2

EUS-guided radiofrequency ablation for pancreatic insulinoma: experience in 2 tertiary centers.

Marx M, Trosic-Ivanisevic T, Caillol F, Demartines N, Schoepfer A, Pesenti C, Ratone JP, Robert M, Giovannini M, Godat S

Gastrointest Endosc. 2022 Jun;95(6):1256-1263

Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response.

Heron V, Li Fraine S, Panaccione N, Restellini S, Germain P, Candido K, Bernstein CN, Bessissow T, Bitton A, Chauhan UK, Lakatos PL, Marshall JK, Michetti P, Seow CH, Rosenfeld G, Panaccione R, Afif W

J Can Assoc Gastroenterol. 2022 Oct;5(5):208-213

Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.

Artru F, Vietti-Violi N, Sempoux C, Vieira Barbosa J, Becce F, Sah N, Marot A, Deltenre P, Moschouri E, Fraga M, Hocquelet A, Duran R, Moradpour D, Rautou PE, Denys A

JHEP Rep. 2022 Aug;4(8):100511

The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection.

Oster P, Vaillant L, McMillan B, Velin D

Front Immunol. 2022;13:899161

Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study.

Vavricka SR, Greuter T, Cohen BL, Reinisch W, Steinwurz F, Fellmann M, Guo X, Lawendy N, Paulissen J, Peyrin-Biroulet L

Therap Adv Gastroenterol. 2022;15:17562848221090834

Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review.

Filippidis P, Vionnet J, Manuel O, Mombelli M

Expert Rev Anti Infect Ther. 2022 May;20(5):663-680

Correction: Efficiency of an endoscopic resection strategy in the management of submucosal tumors less than 20 mm in size and located in the upper gastrointestina.

Caillol F, Meunier E, Zemmour C, Ratone JP, Guiramand J, Pesenti C, Hoibian S, Dahel Y, Marx M, Poizat F, Giovannini M

Endosc Int Open. 2022 Apr;10(4):C4

Positioning biologics in the treatment of IBD: A practical guide - Which mechanism of action for whom?

Juillerat P, Grueber MM, Ruetsch R, Santi G, Vuillèmoz M, Michetti P

Curr Res Pharmacol Drug Discov. 2022;3:100104

Therapy Patterns and Surveillance Measures of Inflammatory Bowel Disease Patients beyond Disease-Related Hospitalization: A Claims-Based Cohort Study.

Bähler C, Brüngger B, Blozik E, Vavricka SR, Schoepfer AM

Inflamm Intest Dis. 2022 Jul;7(2):104-117

Disease burden and unmet need in eosinophilic esophagitis.

Bredenoord AJ, Patel K, Schoepfer AM, Dellon ES, Chehade M, Aceves SS, Spergel JM, Shumel B, Deniz Y, Rowe PJ, Jacob-Nara JA

Am J Gastroenterol. 2022 Apr 13

Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo.

Greuter T, Yaqoob U, Gan C, Jalan-Sakrikar N, Kostallari E, Lu J, Gao J, Sun L, Liu M, Sehrawat TS, Ibrahim SH, Furuta K, Nozickova K, Huang BQ, Gao B, Simons M, Cao S, Shah VH

J Hepatol. 2022 Apr 12

Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme.

Miehlke S, Schlag C, Lucendo AJ, Biedermann L, Vaquero CS, Schmoecker C, Hayat J, Hruz P, Ciriza de Los Rios C, Bredenoord AJ, Vieth M, Schoepfer A, Attwood S, Mueller R, Burrack S, Greinwald R, Straumann A, International EOS-2 Study Group.

United European Gastroenterol J. 2022 Apr;10(3):330-343

A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota.

Messaoudene M, Pidgeon R, Richard C, Ponce M, Diop K, Benlaifaoui M, Nolin-Lapalme A, Cauchois F, Malo J, Belkaid W, Isnard S, Fradet Y, Dridi L, Velin D, Oster P, Raoult D, Ghiringhelli F, Boidot R, Chevrier S, Kysela DT, Brun YV, Falcone EL, Pilon G, Oñ

Cancer Discov. 2022 Apr 1;12(4):1070-1087

Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.

Hu K, Perez-Matos MC, Argemi J, Vilar-Gomez E, Shalaurova I, Bullitt E, Landeen L, Sugahara G, Deng H, Mathur K, Tran S, Cai H, He H, Yalcin Y, Vieira Barbosa J, Ventura-Cots M, Marx K, Gad AP, Niezen S, Izunza Barba S, Ang LH, Popov YV, Fricker Z, Lai M,

Hepatology. 2022 Apr;75(4):968-982

Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD.

Vieira Barbosa J, Milligan S, Frick A, Broestl J, Younossi Z, Afdhal NH, Lai M

Hepatol Commun. 2022 Apr;6(4):765-779

Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis.

Bon L, Safroneeva E, Bussmann C, Biedermann L, Schreiner P, Vavricka SR, Schoepfer AM, McCright-Gill T, Simon HU, Straumann A, Chehade M, Greuter T

United European Gastroenterol J. 2022 Apr;10(3):308-318

GM-CSF is key in the efficacy of vaccine-induced reduction of Helicobacter pylori infection.

Vaillant L, Oster P, McMillan B, Orozco Fernandez E, Velin D

Helicobacter. 2022 Apr;27(2):e12875

Humoral response to SARS-CoV-2 infection among liver transplant recipients.

Becchetti C, Broekhoven AGC, Dahlqvist G, Fraga M, Zambelli MF, Ciccarelli O, Saouli AC, Trizzino A, Banz V, Dufour JF, Roukens AHE, Torres Morales SP, Myeni SK, Kikkert M, Feltkamp MCW, Coenraad MJ

Gut. 2022 Apr;71(4):746-756

Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.

Kasmi S, Artru F, Barbosa JV, Deibel AR, Favre L, Peuble C, Saouli AC, Goossens N, Müllhaupt B, Pascual M, Moradpour D, Vionnet J, Fraga M

Swiss Med Wkly. 2022 Feb 28;152:w30138

Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.

Vieira Barbosa J, Milligan S, Frick A, Broestl J, Younossi Z, Afdhal N, Lai M

Am J Gastroenterol. 2022 Mar 1;117(3):453-461

A homemade endoscopic guillotine strikes again: removal of a nasogastric tube mysteriously knotted in the proximal third of the esophagus.

Pinto do Couto F, Cavin A, Pittet O, Archanioti P, Godat S, Galasso D

Endoscopy. 2022 Feb 18

International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.

Dellon ES, Gonsalves N, Abonia JP, Alexander JA, Arva NC, Atkins D, Attwood SE, Auth MKH, Bailey DD, Biederman L, Blanchard C, Bonis PA, Bose P, Bredenoord AJ, Chang JW, Chehade M, Collins MH, Di Lorenzo C, Dias JA, Dohil R, Dupont C, Falk GW, Ferreira CT

Clin Gastroenterol Hepatol. 2022 Feb 16

Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial.

Dellon ES, Lucendo AJ, Schlag C, Schoepfer AM, Falk GW, Eagle G, Nezamis J, Comer GM, Knoop K, Hirano I

Clin Gastroenterol Hepatol. 2022 Feb 16

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.

Perrig K, Krupka N, Jordi SBU, Rossel JB, Biedermann L, Greuter T, Schreiner P, Vavricka SR, Juillerat P, Burri E, Zimmermann D, Maillard MH, Sulz MC, Brand S, Rogler G, Misselwitz B

Therap Adv Gastroenterol. 2022;15:17562848221074188

Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross-sectional multi-center study.

Greuter T, Straumann A, Fernandez-Marrero Y, Germic N, Hosseini A, Yousefi S, Simon D, Collins MH, Bussmann C, Chehade M, Dellon ES, Furuta GT, Gonsalves N, Hirano I, Moawad FJ, Biedermann L, Safroneeva E, Schoepfer AM, Simon HU

Allergy. 2022 Jan 29

Management of eosinophilic esophagitis associated food impaction in Europe and the United States.

Schreiner P, Safroneeva E, Schoepfer A, Greuter T, Biedermann L, Schlag C, Labenz J, Auth MKH, Bredenoord AJ, Chang JW, Bonis PA, Rothenberg ME, Collins MH, Hirano I, Gupta SK, Katzka DA, Dellon ES, Straumann A, Furuta GT, Gonsalves N

Dis Esophagus. 2022 Jan 28

Benefit of radiofrequency ablation after widespread endoscopic resection of neoplastic Barrett's esophagus in daily practice.

Godat S, Marx M, Caillol F, Robert M, Autret A, Bories E, Pesenti C, Ratone JP, Schoepfer A, Poizat F, Giovannini M

Ann Gastroenterol. 2022 Jan-Feb;35(1):34-41

A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'.

Aksan A, Schoepfer A, Juillerat P, Vavricka S, Bettencourt M, Ramirez de Arellano A, Gavata S, Morin N, Valentine WJ, Hunt B

Adv Ther. 2022 Jan;39(1):815-821

2021

Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.

Marx M, Godat S, Caillol F, Poizat F, Ratone JP, Pesenti C, Schoepfer A, Hoibian S, Dahel Y, Giovannini M

Dig Endosc. 2021 Dec 28

Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study.

Greuter T, Godat A, Ringel A, Almonte HS, Schupack D, Mendoza G, McCright-Gill T, Dellon ES, Hirano I, Alexander J, Chehade M, Safroneeva E, Bussmann C, Biedermann L, Schreiner P, Schoepfer AM, Straumann A, Katzka DA

Clin Gastroenterol Hepatol. 2021 Dec;19(12):2514-2523.e2

Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort.

Schoepfer AM, Tran VDC, Rossel JB, Sokollik C, Spalinger J, Safroneeva E, von Graffenried T, Godat S, Hahnloser D, Vavricka SR, Braegger C, Nydegger A

Inflamm Intest Dis. 2022 Jul;7(2):87-96

Strategies for a two-step liver fibrosis assessment in clinical practice.

Vieira Barbosa J, Lai M

JHEP Rep. 2022 Jan;4(1):100382

Higher educational level in patients with eosinophilic esophagitis: a comparative analysis.

Roth R, Safroneeva E, Saner Zilian C, Schreiner P, Rossel JB, Bopp M, Greuter T, Scharl M, Pittet V, Rogler G, Schoepfer A, Straumann A, Biedermann L

Dis Esophagus. 2021 Sep 9;34(9)

Gastrointestinal quality of life before and short- and long-term after Roux-en-Y gastric bypass for severe obesity.

Waridel C, Schoepfer A, Suter M

Surg Obes Relat Dis. 2021 Sep;17(9):1583-1590

[A practical guide to chronic inflammatory bowel disease].

Salvador Nunes L, Greuter T, Henchoz S, Schoepfer A

Rev Med Suisse. 2021 Sep 1;17(748):1448-1452

[Novelties in digestive endoscopy: three promising endoscopic procedures].

Gfeller É, Romailler É, Ollo D, Robert M, Greuter T, Schoepfer A, Godat S

Rev Med Suisse. 2021 Sep 1;17(748):1443-1447

Clinicopathologic Correlations in Eosinophilic Gastrointestinal Disorders.

Pesek RD, Greuter T, Lopez-Nunez O, Bernieh A, Straumann A, Collins MH

J Allergy Clin Immunol Pract. 2021 Sep;9(9):3258-3266

Impact du Covid-19 sur la gastroentérologie et l’hépatologie.

Schoepfer A, Frossard JL

Rev Med Suisse. 2021 Sep 1;17(748):1435

A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus.

Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators.

Gastroenterology. 2021 Sep;161(3):778-784

Body composition assessment in children with inflammatory bowel disease: A comparison of different methods.

von Graffenried T, Godin JP, Schoepfer A, Breton I, Martin FP, Nydegger A

J Paediatr Child Health. 2021 Sep;57(9):1414-1419

[Autoimmune hepatitis: 2021 update].

Stamm GM, Sempoux C, Fraga M, Comte D, Aubert V, Moradpour D, Vionnet J, Moschouri E

Rev Med Suisse. 2021 Sep 1;17(748):1457-1463

Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis.

Siebenhüner AR, Rossel JB, Schreiner P, Butter M, Greuter T, Krupka N, Jordi SBU, Biedermann L, Rogler G, Misselwitz B, von Känel R

Therap Adv Gastroenterol. 2021;14:17562848211033763

High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.

Herderschee J, Heinonen T, Fenwick C, Schrijver IT, Ohmiti K, Moradpour D, Cavassini M, Pantaleo G, Roger T, Calandra T, Swiss HIV Cohort Study.

Clin Microbiol Infect. 2021 Aug 30

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.

Roth R, Vavricka S, Scharl M, Schreiner P, Safroneeva E, Greuter T, Zeitz J, Misselwitz B, Schoepfer A, Barry MP, Rogler G, Biedermann L, Swiss IBD cohort study.

United European Gastroenterol J. 2021 Aug 25

Non-invasive alloimmune risk stratification of long-term liver transplant recipients.

Vionnet J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E, Feng S, Bucuvalas J, Ferguson J, Quaglia A

J Hepatol. 2021 Aug 23

Is There a Role for Topical Swallowed Steroids upon Emergency Room Admission for Suspected Food Bolus Obstruction in Eosinophilic Esophagitis?

Schreiner P, Greuter T, Tatu A, Keller DI, Straumann A, Biedermann L

Dysphagia. 2021 Aug 16

Hepatitis E Virus RNA-Dependent RNA Polymerase is Involved in RNA Replication and Infectious Particle Production.

Oechslin N, Da Silva N, Szkolnicka D, Cantrelle FX, Hanoulle X, Moradpour D, Gouttenoire J

Hepatology. 2021 Aug 13

Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.

Yoganathan P, Rossel JB, Jordi SBU, Franc Y, Biedermann L, Misselwitz B, Hausmann M, Rogler G, Scharl M, Frey-Wagner I, Swiss IBD cohort study group.

BMC Gastroenterol. 2021 Aug 3;21(1):310

A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease.

Ruiz F, Wyss A, Rossel JB, Sulz MC, Brand S, Moncsek A, Mertens JC, Roth R, Clottu AS, Burri E, Juillerat P, Biedermann L, Greuter T, Rogler G, Pot C, Misselwitz B, Swiss IBD Cohort Study Group.

Br J Pharmacol. 2021 Aug;178(16):3157-3175

Emerging Therapies for Eosinophilic Gastrointestinal Diseases.

Peterson K, Safroneeva E, Schoepfer A

J Allergy Clin Immunol Pract. 2021 Jul 31

Primary hypogammaglobulinemia with IBD-like features: An ECCO CONFER Multicenter Case Series.

Albshesh A, Eder P, Ribaldone DG, Oldenburg B, de Boer NK, Mantzaris GJ, Savarino EV, Dragoni G, Weisshof R, Truyens M, Festa S, Maillard MH, Capirchio L, Filip R, Theodoraki E, Kopylov U

J Crohns Colitis. 2021 Jul 18

FOXC2 controls adult lymphatic endothelial specialization, function, and gut lymphatic barrier preventing multiorgan failure.

González-Loyola A, Bovay E, Kim J, Lozano TW, Sabine A, Renevey F, Arroz-Madeira S, Rapin A, Wypych TP, Rota G, Durot S, Velin D, Marsland B, Guarda G, Delorenzi M, Zamboni N, Luther SA, Petrova TV

Sci Adv. 2021 Jul;7(29)

Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.

Oster P, Vaillant L, Riva E, McMillan B, Begka C, Truntzer C, Richard C, Leblond MM, Messaoudene M, Machremi E, Limagne E, Ghiringhelli F, Routy B, Verdeil G, Velin D

Gut. 2021 Jul 12

Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).

COREOS Collaborators:., Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blan

J Allergy Clin Immunol. 2021 Jul 6

Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy.

Siwicki M, Gort-Freitas NA, Messemaker M, Bill R, Gungabeesoon J, Engblom C, Zilionis R, Garris C, Gerhard GM, Kohl A, Lin Y, Zou AE, Cianciaruso C, Bolli E, Pfirschke C, Lin YJ, Piot C, Mindur JE, Talele N, Kohler RH, Iwamoto Y, Mino-Kenudson M, Pai SI,

Sci Immunol. 2021 Jul 2;6(61)

DIPS, a safe and effective alternative in patients with unfavorable anatomy to TIPSS: first experience in a tertiary center.

Moschouri E, Hocquelet A, Vermersch M, Fraga M, Denys A, Artru F

Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101715

Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease.

Jordi SBU, Botte F, Lang BM, Greuter T, Krupka N, Auschra B, Schreiner P, Sulz MC, Biedermann L, von Känel R, Rogler G, Begré S, Misselwitz B, Swiss IBD cohort study group.

Aliment Pharmacol Ther. 2021 Jul;54(1):53-67

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, Albuquerque A, Allocca M, Esteve M, Farraye FA, Gordon H, Karmiris K, Kopylov U, Kirchgesner J, MacMahon E, Magro F, Maaser C, de Ridder L, Taxonera C, Toruner M, Tremblay L, Scharl M, Vige

J Crohns Colitis. 2021 Jun 22;15(6):879-913

High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.

Halfon M, Artru F, Fraga M, Comte D, Alberio L, Brunet JF, Fakhouri F, Kissling S

Clin Res Hepatol Gastroenterol. 2021 Jun 17;45(5):101734

Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.

Vaillant L, Oster P, McMillan B, Velin D

Vaccine. 2021 Jun 16;39(27):3590-3601

Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis.

Bou Saleh M, Louvet A, Ntandja-Wandji LC, Boleslawski E, Gnemmi V, Lassailly G, Truant S, Maggiotto F, Ningarhari M, Artru F, Anglo E, Sancho-Bru P, Corlu A, Argemi J, Dubois-Chevalier J, Dharancy S, Eeckhoute J, Bataller R, Mathurin P, Dubuquoy L

J Hepatol. 2021 Jun 12

Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.

Jordi SBU, Lang BM, Auschra B, von Känel R, Biedermann L, Greuter T, Schreiner P, Rogler G, Krupka N, Sulz MC, Misselwitz B, Begré S, Swiss IBD Cohort Study Group .

Inflamm Bowel Dis. 2021 Jun 7

Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.

Trivedi HD, Wilechansky R, Goyes D, Vieira Barbosa J, Canakis A, Lai M, Long MT, Fricker Z

Gastroenterology Res. 2021 Jun;14(3):179-183

Eosinophilic esophagitis-established facts and new horizons.

Biedermann L, Straumann A, Greuter T, Schreiner P

Semin Immunopathol. 2021 Jun;43(3):319-335

Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms Following Dilation in Adults With Eosinophilic Esophagitis.

Safroneeva E, Pan Z, King E, Martin LJ, Collins MH, Yang GY, Capocelli KE, Arva NC, Abonia JP, Atkins D, Bonis PA, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Leung J, Menard-Katcher PA, Mukkada VA, Schoepfer AM, Spergel JM, Wershil BK, Rothenber

Clin Gastroenterol Hepatol. 2021 May 29

Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis.

Filippidis P, van Ouwenaller F, Cerutti A, Geiger-Jacquod A, Sempoux C, Pantaleo G, Moradpour D, Lamoth F

F1000Res. 2021;10:400

Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis.

Rubin DT, Reinisch W, Greuter T, Kotze PG, Pinheiro M, Mundayat R, Maller E, Fellmann M, Lawendy N, Modesto I, Vavricka SR, Lichtenstein GR

Therap Adv Gastroenterol. 2021;14:17562848211005708

Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.

Schoepfer AM, Henchoz S, Biedermann L, Schreiner P, Greuter T, Reinhard A, Senn J, Franke A, Burri E, Juillerat P, Simon HU, Straumann A, Safroneeva E, Godat S

Gastrointest Endosc. 2021 May 15

Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease.

Pittet LF, Verolet CM, Michetti P, Gaillard E, Girardin M, Juillerat P, Mottet C, Maillard MH, Siegrist CA, Posfay-Barbe KM, Swiss Inflammatory Bowel Disease Cohort Study Group.

Digestion. 2021 May 10:1-9

Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue.

Vieira Barbosa J, Müllhaupt B, Brunner F, Filipowicz Sinnreich M, Semela D, Montani M, Cathomas G, Neuweiler J, Gouttenoire J, Artru F, Louvet A, Mathurin P, Sempoux C, Lenggenhager D, Weber A, Moradpour D, Fraga M

Swiss Med Wkly. 2021 Apr 26;151:w20502

Lifting the Veil: The Quest for Noninvasive Biomarkers for the Accurate Diagnosis of Eosinophilic Esophagitis.

Straumann A, Greuter T

Dig Dis Sci. 2021 May;66(5):1388-1389

Erratum to: "IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis".

Artru F, Bou Saleh M, Maggiotto F, Lassailly G, Ningarhari M, Demaret J, Ntandja-Wandji LC, Pais de Barros JP, Labreuche J, Drumez E, Helou DG, Dharancy S, Gantier E, Périanin A, Chollet-Martin S, Bataller R, Mathurin P, Dubuquoy L, Louvet A

J Hepatol. 2021 May;74(5):1272-1273

Amino acids in acute-on-chronic liver failure: Another piece of the puzzle?

Coenraad MJ, Artru F

J Hepatol. 2021 May;74(5):1015-1017

Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.

Vieira Barbosa J, Sahli R, Aubert V, Chaouch A, Moradpour D, Fraga M

PLoS One. 2021;16(4):e0250347

[Fecal microbiota transplantation: from the evidence to the realty of the field].

Ballif A, Gerber S, Carrez L, Audry M, Sadeghipour F, Mitouassiwou A, Croxatto A, Opota O, Prod'hom G, Henchoz S, Schoepfer A, Cavassini M, Galpérine T

Rev Med Suisse. 2021 Apr 14;17(734):726-731

Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.

Mader O, Juillerat P, Biedermann L, Michetti P, Hruz P, Pittet V, Rogler G, Zahnd-Straumann N, Seibold F

United European Gastroenterol J. 2021 Apr;9(3):398-406

Emerging treatment options for extraintestinal manifestations in IBD.

Greuter T, Rieder F, Kucharzik T, Peyrin-Biroulet L, Schoepfer AM, Rubin DT, Vavricka SR

Gut. 2021 Apr;70(4):796-802

Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.

Ledergerber M, Lang BM, Heinrich H, Biedermann L, Begré S, Zeitz J, Krupka N, Rickenbacher A, Turina M, Greuter T, Schreiner P, Roth R, Siebenhüner A, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B, Swiss IBD Cohort Study Group.

BMC Gastroenterol. 2021 Feb 5;21(1):53

Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis.

Santi G, Michetti P, Froehlich F, Rossel JB, Pittet V, Maillard MH

Inflamm Intest Dis. 2021 Feb;6(1):25-31

[Advances in gastroenterology and hepatology 2020].

Artru F, Fraga M, Godat S, Schoepfer AM, Moradpour D

Rev Med Suisse. 2021 Jan 13;17(720-1):29-32

How to approach adult patients with asymptomatic esophageal eosinophilia.

Schreiner P, Biedermann L, Greuter T, Wright BL, Straumann A

Dis Esophagus. 2021 Jan 11;34(1)

Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic Esophagitis.

Schoepfer AM, Schürmann C, Trelle S, Zwahlen M, Ma C, Chehade M, Dellon ES, Jairath V, Feagan BG, Bredenoord AJ, Biedermann L, Greuter T, Schreiner P, Straumann A, Safroneeva E

Int Arch Allergy Immunol. 2021;182(12):1169-1193

Food-induced immediate response of the esophagus-A newly identified syndrome in patients with eosinophilic esophagitis.

Biedermann L, Holbreich M, Atkins D, Chehade M, Dellon ES, Furuta GT, Hirano I, Gonsalves N, Greuter T, Gupta S, Katzka DA, De Rooij W, Safroneeva E, Schoepfer A, Schreiner P, Simon D, Simon HU, Warners M, Bredenoord AJ, Straumann A

Allergy. 2021 Jan;76(1):339-347

Crohn's versus Cancer: Comparison of Functional and Surgical Outcomes after Right-Sided Resections.

Grass F, Zhu E, Brunel C, Hübner M, Schoepfer A, Demartines N, Hahnloser D

Dig Dis. 2021;39(2):106-112

Fatigue in inflammatory bowel disease and its impact on daily activities.

Schreiner P, Rossel JB, Biedermann L, Valko PO, Baumann CR, Greuter T, Scharl M, Vavricka SR, Pittet V, Juillerat P, Rogler G, von Känel R, Misselwitz B, Swiss IBD Cohort Study Group.

Aliment Pharmacol Ther. 2021 Jan;53(1):138-149

The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition.

Lenggenhager D, Pawel S, Honcharova-Biletska H, Evert K, Wenzel JJ, Montani M, Furrer E, Fraga M, Moradpour D, Sempoux C, Weber A

Mod Pathol. 2021 Jan;34(1):233-248

Intramedullary spinal cord metastasis of gastric cancer.

Matsumoto H, Shimokawa N, Sato H, Yoshida Y, Takami T

J Craniovertebr Junction Spine. 2021 Jan-Mar;12(1):77-80

Autoimmune hepatitis as a sequelae of oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms.

Droz N, Chevrier F, Lapointe AK, Sempoux C, Fraga M, Comte D

J Allergy Clin Immunol Pract. 2021 Jan;9(1):580-581

Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland.

Aksan A, Schoepfer A, Juillerat P, Vavricka S, Bettencourt M, Ramirez de Arellano A, Gavata S, Morin N, Valentine WJ, Hunt B

Adv Ther. 2021 Jan;38(1):660-677

2020

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.

Andrist CM, Jörg L, Greuter T, Gschwend A, Straumann A, Helbling A

BMC Gastroenterol. 2020 Dec 11;20(1):419

Dilation Modifies Association Between Symptoms and Esophageal Eosinophilia in Adult Patients With Eosinophilic Esophagitis.

Safroneeva E, Cotton CC, Schoepfer AM, Zwahlen M, Woosley JT, Dellon ES

Am J Gastroenterol. 2020 Dec;115(12):2098-2102

Understanding, predicting and achieving liver transplant tolerance: from bench to bedside.

Thomson AW, Vionnet J, Sanchez-Fueyo A

Nat Rev Gastroenterol Hepatol. 2020 Dec;17(12):719-739

Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.

Greuter T, Porchet F, Braga-Neto MB, Rossel JB, Biedermann L, Schreiner P, Scharl M, Schoepfer AM, Safroneeva E, Straumann A, Rogler G, Vavricka SR

United European Gastroenterol J. 2020 Dec;8(10):1196-1207

Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.

Straumann A, Lucendo AJ, Miehlke S, Vieth M, Schlag C, Biedermann L, Vaquero CS, Ciriza de Los Rios C, Schmoecker C, Madisch A, Hruz P, Hayat J, von Arnim U, Bredenoord AJ, Schubert S, Mueller R, Greinwald R, Schoepfer A, Attwood S, International EOS-2 St

Gastroenterology. 2020 Nov;159(5):1672-1685.e5

Increasing Incidence of Microscopic Colitis in a Population-Based Cohort Study in Switzerland.

Maye H, Safroneeva E, Godat S, Sempoux C, Yan P, Bouzourène H, Seelentag W, Stauffer E, Taminelli L, Seibold F, Schoepfer AM

Clin Gastroenterol Hepatol. 2020 Oct 14

Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.

Fraga M, Moradpour D, Artru F, Romailler E, Tschopp J, Schneider A, Chtioui H, Neerman-Arbez M, Casini A, Alberio L, Sempoux C

J Hepatol. 2020 Oct;73(4):967-970

Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection.

Dietz J, Kalinina OV, Vermehren J, Peiffer KH, Matschenz K, Buggisch P, Niederau C, Schattenberg JM, Müllhaupt B, Yerly S, Ringelhan M, Schmid RM, Antoni C, Müller T, Schulze Zur Wiesch J, Piecha F, Moradpour D, Deterding K, Wedemeyer H, Moreno C, Berg T,

J Viral Hepat. 2020 Oct;27(10):974-986

COVID-19 in an international European liver transplant recipient cohort.

Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nev

Gut. 2020 Oct;69(10):1832-1840

Disease Progression and Outcomes of Pregnancies in Women With Eosinophilic Esophagitis.

Schreiner P, Meissgeier S, Safroneeva E, Greuter T, Rogler G, Schoepfer A, Simon D, Simon HU, Biedermann L, Straumann A

Clin Gastroenterol Hepatol. 2020 Oct;18(11):2456-2462

Is Piecemeal Endoscopic Resection Acceptable for Early Colorectal Cancers in Certain Situations? A Single-Center French Study.

Ratone JP, Caillol F, Zemmour C, Bories E, Pesenti C, Godat S, Hoibian S, De Chaisemartin C, Meillat H, Lelong B, Poizat F, Giovannini M

J Gastrointestin Liver Dis. 2020 Sep 9;29(3):353-360

[Hepatocellular adenoma: update 2020].

Romailler É, Schmidt Kobbe S, Moradpour D, Sempoux C

Rev Med Suisse. 2020 Sep 2;16(704):1554-1559

COVID-19 et hépatologie.

Negro F, Moradpour D

Rev Med Suisse. 2020 Sep 2;16(704):1535-1536

[Early TIPS: a practical review after 15 years of scientific evidence].

Shams T, Moschouri E, Denys A, Moradpour D, Fraga M, Artru F

Rev Med Suisse. 2020 Sep 2;16(704):1548-1553

[Pancreatic insufficiency : diagnostic insufficiency ?]

Dombre V, Schoepfer A, Marx M, Robert M, Godat S, David G

Rev Med Suisse. 2020 Sep 2;16(704):1564-1568

Evaluation of Acute Mountain Sickness by Unsedated Transnasal Esophagogastroduodenoscopy at High Altitude.

Fruehauf H, Vavricka SR, Lutz TA, Gassmann M, Wojtal KA, Erb A, Maggiorini M, Schwizer W, Fried M, Fox M, Goetze O, Greuter T

Clin Gastroenterol Hepatol. 2020 Sep;18(10):2218-2225.e2

Follow-Up Ileocolonoscopy Is Underused in Crohn's Disease Patients after Ileocecal Resection despite Higher Total and Inpatient Health-Care Costs Compared to Controls.

Vavricka SR, Greuter T, Brüngger B, Blozik E, Celeiro J, Schoepfer AM, Bähler C

Inflamm Intest Dis. 2020 Aug;5(3):100-108

All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS).

Roelens M, Bertisch B, Moradpour D, Cerny A, Semmo N, Schmid P, Müllhaupt B, Clerc O, Semela D, Junker C, Negro F, Keiser O, Swiss Hepatitis C Cohort Study .

Open Forum Infect Dis. 2020 Aug;7(8):ofaa308

OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease.

Tran HTL, Morikawa K, Anggakusuma, Zibi R, Thi VLD, Penin F, Heim MH, Quadroni M, Pietschmann T, Gouttenoire J, Moradpour D

PLoS One. 2020;15(7):e0236447

Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.

Artru F, Alberio L, Moradpour D, Stalder G

BMJ Case Rep. 2020 Jul 7;13(7)

[Gastroesophageal reflux disease in obese patients ; current management].

Khallouf J, Gaspar Figueiredo S, Demartines N, Schoepfer A, Schäfer M, Mantziari S

Rev Med Suisse. 2020 Jul 1;16(699):1287-1291

Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know.

Schreiner P, Mueller NJ, Fehr J, Maillard MH, Brand S, Michetti P, Schoepfer A, Restellini S, Vulliemoz M, Vavricka SR, Juillerat P, Rogler G, Biedermann L

J Crohns Colitis. 2020 Jun 27

Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea With Enterococcus faecium SF68.

Greuter T, Michel MC, Thomann D, Weigmann H, Vavricka SR

Front Med (Lausanne). 2020;7:276

On the Host Side of the Hepatitis E Virus Life Cycle.

Oechslin N, Moradpour D, Gouttenoire J

Cells. 2020 May 22;9(5)

Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.

Zermatten MG, Fraga M, Calderara DB, Aliotta A, Moradpour D, Alberio L

JHEP Rep. 2020 Aug;2(4):100120

Hepatitis E virus finds its path through the gut.

Oechslin N, Moradpour D, Gouttenoire J

Gut. 2020 May;69(5):796-798

[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak].

Restellini S, Buyse S, Godat S, Goossens N, Maillard MH

Rev Med Suisse. 2020 Apr 29;16(N° 691-2):845-848

[SARS-CoV-2 infection and solid organ transplantation].

Golshayan D, Aubert JD, Hullin R, Moradpour D, Venetz JP, Manuel O, Pascual M

Rev Med Suisse. 2020 Apr 29;16(N° 691-2):815-818

Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer.

Begka C, Pattaroni C, Mooser C, Nancey S, Swiss IBD Cohort Study Group., McCoy KD, Velin D, Maillard MH

iScience. 2020 Mar 27;23(3):100891

[New trends in non-alcoholic fatty liver diseases (NAFLD)].

Barigou M, Favre L, Fraga M, Artru F

Rev Med Suisse. 2020 Mar 25;16(687):586-591

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice.

Wuggenig P, Kaya B, Melhem H, Ayata CK, Swiss IBD Cohort Investigators., Hruz P, Sayan AE, Tsumura H, Ito M, Roux J, Niess JH

Commun Biol. 2020;3:130

Risk factors for candidemia: a prospective matched case-control study.

Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, Neofytos D, Vuotto F, Coiteux V, Artru F, Zimmerli S, Pagani JL, Calandra T, Sendid B, Poulain D, van Delden C, Lamoth F, Marchetti O, Bochud PY, FUNGINOS., Allfun French Study Groups.

Crit Care. 2020 Mar 18;24(1):109

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice.

Wuggenig P, Kaya B, Melhem H, Ayata CK, Swiss IBD Cohort Investigators., Hruz P, Sayan AE, Tsumura H, Ito M, Roux J, Niess JH

Commun Biol. 2020 Mar 18;3(1):130

Treatment Algorithms for Crohn's Disease.

Sulz MC, Burri E, Michetti P, Rogler G, Peyrin-Biroulet L, Seibold F, on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology.

Digestion. 2020 Mar 13:1-15

Medical algorithm: Diagnosis and treatment of eosinophilic esophagitis in adults.

Greuter T, Straumann A

Allergy. 2020 Mar;75(3):727-730

Hepatitis A and E - Differences and commonalities.

Gotlieb N, Moradpour D, Shouval D

J Hepatol. 2020 Mar;72(3):578-580

Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.

Schoepfer A, Vavricka SR, Brüngger B, Blozik E, Bähler C

Eur J Gastroenterol Hepatol. 2020 Mar;32(3):350-357

Haemostatic alterations in cirrhotic patients: from primary haemostasis to fibrinolysis.

Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Stirnimann G, De Gottardi A, Alberio L

Hepatology. 2020 Feb 23

Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.

Nat Commun. 2020 Feb 21;11(1):995

Combined lung and liver transplantation for short telomere syndrome.

Moschouri E, Vionnet J, Giostra E, Daccord C, Lazor R, Sciarra A, Letovanec I, Sempoux C, Gonzalez M, Unger S, Fodstad H, Haubitz M, Baerlocher GM, Voruz S, Naveiras O, Jacquemin E, Moradpour D, Fraga M

Liver Transpl. 2020 Feb 20

Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?

Bertisch B, Brezzi M, Negro F, Müllhaupt B, Ottiger C, Künzler-Heule P, Schmid P, Giudici F, Clerc O, Moriggia A, Roelens M, Marinucci F, Zehnder C, Moradpour D, Keiser O, Swiss Hepatitis C Cohort Study .

Clin Infect Dis. 2020 Feb 3;70(4):653-659

Quatre atouts à ramener à votre cabinet sur les maladies inflammatoires de l’intestin.

Michetti P

Rev Med Suisse. 2020 Jan 29;16(679):212-213

Vaccination in Patients with Inflammatory Bowel Diseases.

Manser CN, Maillard MH, Rogler G, Schreiner P, Rieder F, Bühler S

Digestion. 2020 Jan 22:1-11

Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update.

Burri E, Maillard MH, Schoepfer AM, Seibold F, Van Assche G, Rivière P, Laharie D, Manz M

Digestion. 2020 Jan 16:1-14

IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis.

J Hepatol. 2020 Jan 15

Management of the Elderly Inflammatory Bowel Disease Patient.

Hruz P, Juillerat P, Kullak-Ublick GA, Schoepfer AM, Mantzaris GJ, Rogler G

Digestion. 2020 Jan 14:1-15

Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding.

Restellini S, Biedermann L, Hruz P, Mottet C, Moens A, Ferrante M, Schoepfer AM

Digestion. 2020 Jan 8:1-16

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.

Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A

Gastroenterology. 2020 Jan;158(1):111-122.e10

Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis Therapies.

Safroneeva E, Hafner D, Kuehni CE, Zwahlen M, Trelle S, Biedermann L, Greuter T, Vavricka SR, Straumann A, Schoepfer AM

Int Arch Allergy Immunol. 2020;181(3):211-220

Outcomes of duodenal stenting: Experience in a French tertiary center with 220 cases.

Ratone JP, Caillol F, Zemmour C, Bories E, Pesenti C, Lestelle V, Godat S, Hoibian S, Proux A, Capodano G, Giovannini M

Dig Liver Dis. 2020 Jan;52(1):51-56

GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway.

Yaqoob U, Luo F, Greuter T, Jalan Sakrikar N, Sehrawat TS, Lu J, Hu X, Gao J, Kostallari E, Chen J, Arab JP, Martin-Mateos R, Cao S, Shah VH

Cell Mol Gastroenterol Hepatol. 2020;10(3):545-559

Emerging therapies for eosinophilic esophagitis.

Greuter T, Hirano I, Dellon ES

J Allergy Clin Immunol. 2020 Jan;145(1):38-45

Gender Differences in Inflammatory Bowel Disease.

Greuter T, Manser C, Pittet V, Vavricka SR, Biedermann L, on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology.

Digestion. 2020;101 Suppl 1:98-104

Malignancies in Inflammatory Bowel Disease.

Greuter T, Vavricka S, König AO, Beaugerie L, Scharl M, Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology.

Digestion. 2020;101 Suppl 1:136-145

2019

Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.

Sun W, Li S, Tang G, Luo Y, Ma S, Sun S, Ren J, Gong Y, Xie C

Int J Nanomedicine. 2019;14:10195-10207

Neurologic complications of acute hepatitis E virus infection.

Ripellino P, Pasi E, Melli G, Staedler C, Fraga M, Moradpour D, Sahli R, Aubert V, Martinetti G, Bihl F, Bernasconi E, Terziroli Beretta-Piccoli B, Cerny A, Dalton HR, Zehnder C, Mathis B, Zecca C, Disanto G, Kaelin-Lang A, Gobbi C

Neurol Neuroimmunol Neuroinflamm. 2020 Jan;7(1)

Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.

Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L, Swiss IBD Cohort Study Group.

Dig Dis Sci. 2019 Dec 3

Position statement on the use of biosimilars in inflammatory bowel disease.

Burri E, Juillerat P, Maillard MH, Manz M, Michetti P, Mottet C, Rogler G, Zahnd N, Vavricka S

Swiss Med Wkly. 2019 Dec 2;149:w20148

Acinar cell carcinoma of the pancreas with thyroid-like follicular features: first description of a new diagnostic challenging subtype.

Saglietti C, Schneider V, Bongiovanni M, Missiaglia E, Bisig B, Dorta G, Demartines N, Sempoux C, La Rosa S

Virchows Arch. 2019 Dec;475(6):789-794

Erratum to "Approaches for patients with very high MELD scores".

Artru F, Samuel D

JHEP Rep. 2019 Nov;1(5):414

Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.

Dietz J, Spengler U, Müllhaupt B, Schulze Zur Wiesch J, Piecha F, Mauss S, Seegers B, Hinrichsen H, Antoni C, Wietzke-Braun P, Peiffer KH, Berger A, Matschenz K, Buggisch P, Backhus J, Zizer E, Boettler T, Neumann-Haefelin C, Semela D, Stauber R, Berg T,

Clin Gastroenterol Hepatol. 2019 Nov 6

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing.

About F, Bibert S, Jouanguy E, Nalpas B, Lorenzo L, Rattina V, Zarhrate M, Hanein S, Munteanu M, Müllhaupt B, Semela D, Semmo N, Casanova JL, Theodorou I, Sultanik P, Poynard T, Pol S, Bochud PY, Cobat A, Abel L, Swiss Hepatitis C Cohort Study Group., Fre

Front Genet. 2019;10:1024

Which psychosocial variables affect drive the most? Analysis of sexual desire in a group of Italian men.

Nimbi FM, Tripodi F, Rossi R, Michetti PM, Simonelli C

Int J Impot Res. 2019 Nov;31(6):410-423

Synchronous tumors of the pancreas and the gallbladder: a case report with targeted NGS evaluation.

Sivade A, Sempoux C, Voutsadakis I, Brunel C, Halkic N, Godat S, Duran R, Digklia A

Ann Transl Med. 2019 Nov;7(22):696

Simple and Simply the Best? Dublin in the European Spotlight.

Vavricka SR, Greuter T

J Crohns Colitis. 2019 Oct 28;13(11):1363-1364

Real-World Data on Topical Therapies and Annual Health Resource Utilization in Hospitalized Swiss Patients with Ulcerative Colitis.

Baehler C, Brüngger B, Blozik E, Vavricka SR, Schoepfer AM

Inflamm Intest Dis. 2019 Oct;4(4):144-153

Reply.

Greuter T, Schoepfer AM, Straumann A

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2385-2386

Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn's Disease.

Schoepfer A, Santos J, Fournier N, Schibli S, Spalinger J, Vavricka S, Safroneeva E, Aslan N, Rogler G, Braegger C, Nydegger A

J Crohns Colitis. 2019 Sep 27;13(10):1334-1342

Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study.

Frei R, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L

J Crohns Colitis. 2019 Sep 27;13(10):1292-1301

Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein.

Szkolnicka D, Pollán A, Da Silva N, Oechslin N, Gouttenoire J, Moradpour D

J Virol. 2019 Oct 1;93(19)

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.

Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M, Shabafrouz K, Ribi C, Cairoli A, Guex-Crosier Y, Kuntzer T, Michielin O, Peters S, Coukos G, Spertini F, Thompson JA, Obeid M

Nat Rev Clin Oncol. 2019 Sep;16(9):563-580

Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.

Pittet VEH, Maillard MH, Simonson T, Fournier N, Rogler G, Michetti P, Swiss IBD Cohort Study Group(∗).

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2050-2059.e1

[Alagille Syndrome].

Wakim El-Khoury J, Venetz JP, Rutz T, Sciarra A, Unger S, Sempoux C, Moradpour D, Fraga M

Rev Med Suisse. 2019 Aug 28;15(660):1506-1510

[Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner].

Henchoz S, Fraga M, Saouli AC, Elkrief L, Berney T, Toso C, Compagnon P, Andres A, Denys A, Pascual M, Moradpour D, Giostra E, Vionnet J

Rev Med Suisse. 2019 Aug 28;15(660):1488-1495

[Abecedary of colonic polyps].

Archanioti P, Bornand A, Sempoux C, Unger S, Schoepfer A, Robert M, David G

Rev Med Suisse. 2019 Aug 28;15(660):1483-1487

L’hépatologie opère sa mue.

Moradpour D, Frossard JL

Rev Med Suisse. 2019 Aug 28;15(660):1475-1476

Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus.

Greuter T, Maillard MH, Juillerat P, Michetti P, Seibold F, Mottet C, Zahnd N, Sauter B, Schoepfer AM, Rogler G, Vavricka SR, on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology.

Digestion. 2019 Aug 28:1-9

Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents.

Terziroli Beretta-Piccoli B, Di Bartolomeo C, Deleonardi G, Grondona AG, Silvestri T, Tesei C, Melidona L, Cerny A, Mertens J, Semmo N, Semela D, Moradpour D, Mieli-Vergani G, Vergani D, Muratori L, Swiss Hepatitis C Cohort Study.

J Autoimmun. 2019 Aug;102:89-95

Editorial: when cirrhosis deserves haemodialysis-rethinking strategies. Authors' reply.

Artru F, Louvet A, Hazzan M, Mathurin P

Aliment Pharmacol Ther. 2019 Aug;50(4):457-458

Gastroparesis and Dumping Syndrome: Current Concepts and Management.

Vavricka SR, Greuter T

J Clin Med. 2019 Jul 29;8(8)

The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis.

Artru F, Louvet A, Glowacki F, Bellati S, Frimat M, Gomis S, Castel H, Barthelon J, Lassailly G, Dharancy S, Noel C, Hazzan M, Mathurin P

Aliment Pharmacol Ther. 2019 Jul;50(1):75-83

Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease.

Schreiner P, Yilmaz B, Rossel JB, Franc Y, Misselwitz B, Scharl M, Zeitz J, Frei P, Greuter T, Vavricka SR, Pittet V, Siebenhüner A, Juillerat P, von Känel R, Macpherson AJ, Rogler G, Biedermann L, Swiss IBD Cohort Study Group.

United European Gastroenterol J. 2019 Jul;7(6):767-781

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.

Schoepfer AM, Hirano I, Coslovsky M, Roumet MC, Zwahlen M, Kuehni CE, Hafner D, Alexander JA, Dellon ES, Gonsalves N, Leung J, Bussmann C, Collins MH, Newbury RO, Smyrk TC, Woosley JT, Yang GY, Romero Y, Katzka DA, Furuta GT, Gupta SK, Aceves SS, Chehade

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1477-1488.e10

High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.

Pittet LF, Verolet CM, Michetti P, Girardin M, Juillerat P, Mottet C, Maillard MH, Siegrist CA, Posfay-Barbe KM, Swiss Inflammatory Bowel Disease Cohort Study Group.

Am J Gastroenterol. 2019 Jul;114(7):1130-1141

Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study.

Brezzi M, Bertisch B, Roelens M, Moradpour D, Terziroli Beretta-Piccoli B, Semmo N, Müllhaupt B, Semela D, Negro F, Keiser O, Swiss Hepatitis C Cohort Study.

PLoS One. 2019;14(6):e0218706

Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules.

Lassailly G, Bou Saleh M, Leleu-Chavain N, Ningarhari M, Gantier E, Carpentier R, Artru F, Gnemmi V, Bertin B, Maboudou P, Betbeder D, Gheeraert C, Maggiotto F, Dharancy S, Mathurin P, Louvet A, Dubuquoy L

J Hepatol. 2019 Jun;70(6):1159-1169

The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.

Pillai N, Dusheiko M, Maillard MH, Rogler G, Brüngger B, Bähler C, Pittet VEH, Swiss IBD Cohort Study Group .

J Crohns Colitis. 2019 May 27;13(6):744-754

Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.

Fraga M, Gouttenoire J, Sahli R, Chtioui H, Marcu C, Pascual M, Moradpour D, Vionnet J

BMC Gastroenterol. 2019 May 24;19(1):76

Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland.

Sahli R, Fraga M, Semela D, Moradpour D, Gouttenoire J

J Hepatol. 2019 May;70(5):1023-1025

Maf deficiency in T cells dysregulates Treg - TH17 balance leading to spontaneous colitis.

Imbratta C, Leblond MM, Bouzourène H, Speiser DE, Velin D, Verdeil G

Sci Rep. 2019 Apr 16;9(1):6135

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

Pittet V, Michetti P, Mueller C, Braegger CP, von Känel R, Schoepfer A, Macpherson AJ, Rogler G, Swiss IBD Cohort Study Group.

Int J Epidemiol. 2019 Apr 1;48(2):385-386f

Symptom-based patient-reported outcomes in adults with eosinophilic esophagitis: value for treatment monitoring and randomized controlled trial design.

Safroneeva E, Schoepfer AM

Curr Opin Allergy Clin Immunol. 2019 Apr;19(2):169-174

Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease.

Yilmaz B, Juillerat P, Øyås O, Ramon C, Bravo FD, Franc Y, Fournier N, Michetti P, Mueller C, Geuking M, Pittet VEH, Maillard MH, Rogler G, Swiss IBD Cohort Investigators., Wiest R, Stelling J, Macpherson AJ

Nat Med. 2019 Apr;25(4):701

Vedolizumab in Refractory Microscopic Colitis: An International Case Series.

Rivière P, Münch A, Michetti P, Chande N, de Hertogh G, Schoeters P, Ferrante M, Vermeire S, Van Assche G

J Crohns Colitis. 2019 Mar 26;13(3):337-340

Fluid collection after partial pancreatectomy: EUS drainage and long-term follow-up.

Caillol F, Godat S, Turrini O, Zemmour C, Bories E, Pesenti C, Ratone JP, Ewald J, Delpero JR, Giovannini M

Endosc Ultrasound. 2019 Mar-Apr;8(2):91-98

Approaches for patients with very high MELD scores.

Artru F, Samuel D

JHEP Rep. 2019 May;1(1):53-65

Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients.

Asgari S, Chaturvedi N, Scepanovic P, Hammer C, Semmo N, Giostra E, Müllhaupt B, Angus P, Thompson AJ, Moradpour D, Fellay J

J Viral Hepat. 2019 Feb;26(2):271-277

Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients.

Greuter T, Safroneeva E, Bussmann C, Biedermann L, Vavricka SR, Katzka DA, Schoepfer AM, Straumann A

Clin Gastroenterol Hepatol. 2019 Feb;17(3):419-428.e6

Microbial network disturbances in relapsing refractory Crohn's disease.

Nat Med. 2019 Feb;25(2):323-336

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.

Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES, HEROES St

Gastroenterology. 2019 Feb;156(3):592-603.e10

The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation.

Tcymbarevich IV, Eloranta JJ, Rossel JB, Obialo N, Spalinger M, Cosin-Roger J, Lang S, Kullak-Ublick GA, Wagner CA, Scharl M, Seuwen K, Ruiz PA, Rogler G, de Vallière C, Misselwitz B, Swiss IBD Cohort Study Group.

BMC Gastroenterol. 2019 Jan 7;19(1):2

Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.

Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T

Am J Gastroenterol. 2019 Jan;114(1):116-126

Chronisch entzündliche Darmerkrankungen.

Schoepfer A

Ther Umsch. 2019 Jan;75(5):253

Characterization of subepithelial lesions of the stomach and esophagus by contrast-enhanced EUS: A retrospective study.

Pesenti C, Bories E, Caillol F, Ratone JP, Godat S, Monges G, Poizat F, Raoul JL, Ries P, Giovannini M

Endosc Ultrasound. 2019 Jan-Feb;8(1):43-49

[Epidemiology and socio-economic aspects of chronic inflammatory bowel diseases in Switzerland].

Schoepfer A, Safroneeva E

Ther Umsch. 2019 Jan;75(5):255-259

Schwangerschaftsassoziierte Lebererkrankungen

Fraga M und Moradpour - Book Chapter

In: Referenz Gastroenterologie. Riemann JF, Fischbach W, Galle PR, Mössner J, Hrsg. Georg Thieme Verlag, Stuttgart - New York, 2019, pp. 787-794.

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.

Martins F, Sykiotis GP, Maillard M, Fraga M, Ribi C, Kuntzer T, Michielin O, Peters S, Coukos G, Spertini F, Thompson JA, Obeid M

Lancet Oncol. 2019 Jan;20(1):e54-e64

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.

Kolios AGA, Hueber AJ, Michetti P, Mrowietz U, Mustak-Blagusz M, Sator PG, Reinshagen M, Wilsmann-Theis D, Gomis-Kleindienst S, Luckey U, Rössler A, Schiefke I

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):234-241

2018

Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion.

Gouttenoire J, Pollán A, Abrami L, Oechslin N, Mauron J, Matter M, Oppliger J, Szkolnicka D, Dao Thi VL, van der Goot FG, Moradpour D

PLoS Pathog. 2018 Dec;14(12):e1007471

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.

Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L, Godat S, Nydegger A, Scharl M, Rogler G, Vavricka SR, Schoepfer AM, Swiss IBD Cohort Study Group.

J Crohns Colitis. 2018 Nov 28;12(12):1399-1409

Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes.

Safroneeva E, Balsiger L, Hafner D, Kuehni CE, Zwahlen M, Trelle S, Godat S, Biedermann L, Greuter T, Vavricka S, Straumann A, Schoepfer AM

Aliment Pharmacol Ther. 2018 Nov;48(10):1082-1090

Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review.

Ma C, van Rhijn BD, Jairath V, Nguyen TM, Parker CE, Aceves SS, Furuta GT, Gupta SK, Katzka DA, Safroneeva E, Schoepfer AM, Straumann A, Spergel JM, Pai RK, Feagan BG, Hirano I, Dellon ES, Bredenoord AJ

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1714-1729.e3

Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs.

Saleh M, Welsch C, Cai C, Döring C, Gouttenoire J, Friedrich J, Haselow K, Sarrazin C, Badenhoop K, Moradpour D, Zeuzem S, Rueschenbaum S, Lange CM

J Steroid Biochem Mol Biol. 2018 Oct;183:142-151

Clostridium – si difficile et si onéreux.

Frossard JL, Moradpour D

Rev Med Suisse. 2018 Aug 29;14(616):1483

[Functional gastrointestinal disorders: update on the Rome IV criteria].

Marx M, Maye H, Abdelrahman K, Hessler R, Moschouri E, Aslan N, Godat S, Nichita C, Wiesel P, Perez L, Schoepfer AM

Rev Med Suisse. 2018 Aug 29;14(616):1512-1516

[Primary biliary cholangitis : an update].

Vieira Barbosa J, Vionnet J, Sciarra A, Sempoux C, Aubert V, Moradpour D, Fraga Christinet M

Rev Med Suisse. 2018 Aug 29;14(616):1489-1494

[Endoscopic ultrasound - guided biliary and pancreatic drainage: an update].

Aslan N, Schoepfer A, Robert M, David G, Moschouri E, Galasso D, Godat S

Rev Med Suisse. 2018 Aug 29;14(616):1495-1498

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.

Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M, Swiss IBD Cohort Study Group .

Inflamm Bowel Dis. 2018 Jul 12;24(8):1768-1779

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L, Swiss IBD Cohort Study Group .

J Crohns Colitis. 2018 Jun 28;12(7):811-818

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.

Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM, Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):612-620

EASL Clinical Practice Guidelines on hepatitis E virus infection.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., European Association for the Study of the Liver.

J Hepatol. 2018 Jun;68(6):1256-1271

Patient-reported healthcare expectations in inflammatory bowel diseases.

Pittet V, Vaucher C, Froehlich F, Maillard MH, Michetti P, Swiss IBD Cohort Study Group.

PLoS One. 2018;13(5):e0197351

Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation.

Vionnet J, Yerly P, Aubert JD, Pascual M, Aldenkortt F, Berney T, Giostra E, Moradpour D, Schiffer E

Transplantation. 2018 May;102(5):e194

Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.

Fraga M, Doerig C, Moulin H, Bihl F, Brunner F, Müllhaupt B, Ripellino P, Semela D, Stickel F, Terziroli Beretta-Piccoli B, Aubert V, Telenti A, Greub G, Sahli R, Moradpour D

Liver Int. 2018 Apr;38(4):619-626

Targeting Endoplasmic Reticulum and/or Mitochondrial Ca2+ Fluxes as Therapeutic Strategy for HCV Infection.

Scrima R, Piccoli C, Moradpour D, Capitanio N

Front Chem. 2018;6:73

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies.

Bartenschlager R, Baumert TF, Bukh J, Houghton M, Lemon SM, Lindenbach BD, Lohmann V, Moradpour D, Pietschmann T, Rice CM, Thimme R, Wakita T

Virus Res. 2018 Mar 15;248:53-62

Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.

Trépo E, Goossens N, Fujiwara N, Song WM, Colaprico A, Marot A, Spahr L, Demetter P, Sempoux C, Im GY, Saldarriaga J, Gustot T, Devière J, Thung SN, Minsart C, Sersté T, Bontempi G, Abdelrahman K, Henrion J, Degré D, Lucidi V, Rubbia-Brandt L, Nair VD, Mo

Gastroenterology. 2018 Mar;154(4):965-975

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Serrero M, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B, Groupe d'Etude Thérapeutique

Aliment Pharmacol Ther. 2018 Mar;47(5):588-595

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.

Schoepfer AM, Simko A, Bussmann C, Safroneeva E, Zwahlen M, Greuter T, Biedermann L, Vavricka S, Godat S, Reinhard A, Saner C, Maye H, Sempoux C, Brunel C, Blanchard C, Simon D, Simon HU, Straumann A

Am J Gastroenterol. 2018 Mar;113(3):348-357

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Safroneeva E, Saner C, Rossel JB, Golay D, Pittet V, Godat S, Diem S, Aepli P, Sawatzki M, Borovicka J, Burgmann K, Juillerat P, Netzer P, Sendensky A, Hruz P, Girardin M, Biedermann L, Greuter T, Vavricka S, Michetti P, Mueller C, Straumann A, Schoepfer

Inflamm Intest Dis. 2018 Mar;2(3):163-170

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.

Dietz J, Susser S, Vermehren J, Peiffer KH, Grammatikos G, Berger A, Ferenci P, Buti M, Müllhaupt B, Hunyady B, Hinrichsen H, Mauss S, Petersen J, Buggisch P, Felten G, Hüppe D, Knecht G, Lutz T, Schott E, Berg C, Spengler U, von Hahn T, Berg T, Zeuzem S,

Gastroenterology. 2018 Mar;154(4):976-988.e4

Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.

Vavricka SR, Galván JA, Dawson H, Soltermann A, Biedermann L, Scharl M, Schoepfer AM, Rogler G, Prinz Vavricka MB, Terracciano L, Navarini A, Zlobec I, Lugli A, Greuter T

J Crohns Colitis. 2018 Feb 28;12(3):347-354

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.

Greuter T, Franc Y, Kaelin M, Schoepfer AM, Schreiner P, Zeitz J, Scharl M, Misselwitz B, Straumann A, Vavricka SR, Rogler G, von Känel R, Biedermann L

Therap Adv Gastroenterol. 2018;11:1756283X18757715

Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.

Wu X, Dao Thi VL, Liu P, Takacs CN, Xiang K, Andrus L, Gouttenoire J, Moradpour D, Rice CM

Gastroenterology. 2018 Feb;154(3):663-674.e7

Trends in hepatitis C-related mortality in Switzerland.

Keiser O, Giudici F, Müllhaupt B, Junker C, Dufour JF, Moradpour D, Bruggmann P, Terziroli B, Semela D, Brezzi M, Bertisch B, Estill J, Negro F, Spoerri A, Swiss Hepatitis C Cohort Study and the Swiss National Cohort.

J Viral Hepat. 2018 Feb;25(2):152-160

Heterotopic Gastric Mucosa in a Duplication Cyst of the Common Hepatic Duct Mimicking Cholangiocarcinoma.

Sciarra A, Hessler R, Godat S, Fraga M, Dromain C, Duran R, Halkic N, Sempoux C

Int J Surg Pathol. 2018 Feb;26(1):84-88

[Boerhaave syndrome: update on physiopathology, diagnosis and early management].

Lu H, Carron PN, Godat S, Pittet R

Rev Med Suisse. 2018 Jan 31;14(592):299-303

Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease.

Lang BM, Biedermann L, van Haaften WT, de Vallière C, Schuurmans M, Begré S, Zeitz J, Scharl M, Turina M, Greuter T, Schreiner P, Heinrich H, Kuntzen T, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B, Swiss IBD Cohort Study Group.

Aliment Pharmacol Ther. 2018 Jan;47(1):55-66

Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis.

Safroneeva E, Straumann A, Schoepfer AM

Gastrointest Endosc Clin N Am. 2018 Jan;28(1):35-45

Pharmacologic Treatment of Eosinophilic Esophagitis: An Update.

Schoepfer AM, Straumann A, Safroneeva E

Gastrointest Endosc Clin N Am. 2018 Jan;28(1):77-88

Management of severe portopulmonary hypertension with dual oral therapy prior to liver transplantation.

Vionnet J, Yerly P, Aubert J-D, Pascual M, Aldenkortt F, Berney T, Giostra E, Moradpour D, Schiffer E

Transplantation, in press.

Ikterus. In: Siegenthalers Differenzialdiagnose. Innere Krankheiten - vom Symptom zur Diagnose.

Moradpour D und Blum HE

Battegay E, Hrsg. 21. Auflage. Georg Thieme Verlag, Stuttgart - New York, in press.

Rapid remission of Graves hyperthyroidism without thionamides under immunosuppressive treatment for concomitant autoimmune hepatitis.

Papadakis GE, Lamine F, Chtioui H, Moschouri E, Fraga Christinet M, Sciarra A, Sempoux C, Schneider A, Duss F-R, Sartori C, Moradpour D, Sykiotis GP

Thyroid, in press.

Klinische Pathophysiologie.

Moradpour D und Lammert F. Leber

Blum HE und Müller-Wieland D, Hrsg. 10. Auflage, Georg Thieme Verlag, Stuttgart - New York, in press.

Effect of hepatitis B virus on steatosis in hepatitis C virus coinfected subjects: a multicenter study and systematic review.

Goossens N, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, Lampertico P, Coppola N, Zampino R, Stanzione M, Adinolfi LE, Wedemeyer H, Semmo N, Müllhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, on be

J Viral Hepat, in press.

Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication.

Farhat R, Ankavay M, Lebsir N, Gouttenoire J, Jackson CL, Wychowski C, Moradpour D, Dubuisson J, Rouillé Y, Cocquerel L

Cell Microbiol. 2018 Jan;20(1)

[From Molecuar to Natural Medicine].

Allgaier HP, Arnold C, Baumert TF, Becker G, Geißler M, Hafkemeyer P, Harder J, Heim MH, Huber R, Kern WV, Mohr L, Moradpour D, Offensperger S, Offensperger WB, Spangenberg HC, Thimme R, Walter E, von Weizsäcker F

Dtsch Med Wochenschr. 2018 Jan;143(1):40-45

Celiac Disease is Misdiagnosed Based on Serology Only in a Substantial Proportion of Patients.

Vavricka SR, Stelzer T, Lattmann J, Stotz M, Lehmann R, Zeitz J, Scharl M, Misselwitz B, Pohl D, Fried M, Tutuian R, Fasano A, Schoepfer AM, Rogler G, Biedermann L, Greuter T

J Clin Gastroenterol. 2018 Jan;52(1):25-29

2017

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.

Marot A, Belaid A, Orlent H, Sersté T, Michielsen P, Colle I, Laleman W, de Galocsy C, Reynaert H, D'Heygere F, Moreno C, Doerig C, Henrion J, Deltenre P

Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):656-663

Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.

Bruggmann P, Blach S, Deltenre P, Fehr J, Kouyos R, Lavanchy D, Müllhaupt B, Rauch A, Razavi H, Schmid P, Semela D, Stoeckle M, Negro F

Swiss Med Wkly. 2017;147:w14543

Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.

Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P

PLoS One. 2017;12(10):e0186715

A systematic review and meta-analysis of HCV clearance.

Gauthiez E, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Heim MH, Malinverni R, Moradpour D, Müllhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud PY, Swiss Hepatitis C Cohort Study.

Liver Int. 2017 Oct;37(10):1431-1445

Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.

Vionnet J, Pascual M, Testoni B, Combet C, Godat S, Vijgen S, Aubert V, Rubbia-Brandt L, Zoulim F, Moradpour D

Hepatology. 2017 Sep 16

Visualization of hepatitis E virus RNA and proteins in the human liver.

Lenggenhager D, Gouttenoire J, Malehmir M, Bawohl M, Honcharova-Biletska H, Kreutzer S, Semela D, Neuweiler J, Hürlimann S, Aepli P, Fraga M, Sahli R, Terracciano L, Rubbia-Brandt L, Müllhaupt B, Sempoux C, Moradpour D, Weber A

J Hepatol. 2017 Sep;67(3):471-479

[Management of ulcerative colitis in 2017].

Moschouri E, Hessler R, Pittet V, Velin D, Conrad C, Hahnloser D, Gié O, Michetti P, Schoepfer AM, Maillard MH

Rev Med Suisse. 2017 Aug 30;13(572):1480-1486

[Hepatopulmonary syndrome and portopulmonary hypertension].

Marcu C, Schiffer E, Aubert JD, Vionnet J, Yerly P, Deltenre P, Marot A

Rev Med Suisse. 2017 Aug 30;13(572):1464-1469

Hépatite E : qui cherche… trouve.

Moradpour D, Frossard JL

Rev Med Suisse. 2017 Aug 30;13(572):1451-1452

Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy.

van Eijk JJJ, Dalton HR, Ripellino P, Madden RG, Jones C, Fritz M, Gobbi C, Melli G, Pasi E, Herrod J, Lissmann RF, Ashraf HH, Abdelrahim M, Masri OABAL, Fraga M, Benninger D, Kuntzer T, Aubert V, Sahli R, Moradpour D, Blasco-Perrin H, Attarian S, Gérolam

Neurology. 2017 Aug 29;89(9):909-917

Akute und chronische Hepatitis E.

Fraga M, Gouttenoire J, Sahli R, Moradpour D

Ther Umsch. 2017 Jul;74(3):109-113

Effect of abstinence on the prognosis of patients with alcoholic liver disease: A word of caution.

Deltenre P, Marot A, Knebel JF, Doerig C, Henrion J, Moreno C

J Hepatol. 2017 Jun;66(6):1329-1330

Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.

De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J, Puente A, Müllhaupt B, Navascuès C, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek FWG

Liver Int. 2017 May;37(5):694-699

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.

Béguelin C, Friolet N, Moradpour D, Sahli R, Suter-Riniker F, Lüthi A, Cavassini M, Günthard HF, Battegay M, Bernasconi E, Schmid P, Calmy A, Atkinson A, Rauch A, Wandeler G, Swiss HIV Cohort Study.

Clin Infect Dis. 2017 May 1;64(9):1275-1278

Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding.

Marot A, Trépo E, Doerig C, Schoepfer A, Moreno C, Deltenre P

Liver Int. 2017 May;37(5):707-716

External validation of the nomogram for individualized prediction of hepatocellular carcinoma occurrence in patients with hepatitis C virus-related compensated cirrhosis.

Marot A, Vandenbulcke H, Knebel JF, Doerig C, Moreno C, Deltenre P

Hepatology. 2017 Apr;65(4):1419-1421

Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.

Monier A, Guiu B, Duran R, Aho S, Bize P, Deltenre P, Dunet V, Denys A

Eur Radiol. 2017 Apr;27(4):1431-1439

Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.

Béguelin C, Moradpour D, Sahli R, Suter-Riniker F, Lüthi A, Cavassini M, Günthard HF, Battegay M, Bernasconi E, Schmid P, Calmy A, Braun DL, Furrer H, Rauch A, Wandeler G, Swiss HIV Cohort Study.

J Hepatol. 2017 Feb;66(2):297-303

A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis.

Ambregna S, Koch S, Sulz MC, Grüner B, Öztürk S, Chevaux JB, Sulima M, de Gottardi A, Napoléon B, Abergel A, Bichard P, Boytchev I, Deprez P, Dumortier J, Frossard JL, Kull E, Meny B, Moradpour D, Prat F, Vanbiervliet G, Thevenot T, Vuitton DA, Bresson-Ha

Expert Rev Anti Infect Ther. 2017 Jan;15(1):79-88

Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.

Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, Nydegger A, Vavricka SR, Moradpour D, Schoepfer AM, Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2017 Jan;29(1):91-97

IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice.

Moyat M, Bouzourene H, Ouyang W, Iovanna J, Renauld JC, Velin D

Mucosal Immunol. 2017 Jan;10(1):271-281

2016

How to measure disease activity in eosinophilic esophagitis.

Schoepfer A, Safroneeva E, Straumann A

Dis Esophagus. 2016 Nov;29(8):959-966

Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease.

Vionnet J, Saouli AC, Pascual M, Stucker F, Decosterd LA, Moradpour D, Chtioui H

J Hepatol. 2016 Nov;65(5):1063-1065

Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing.

Gouttenoire J, Szkolnicka D, Moradpour D

Gut. 2016 Oct;65(10):1583-4

Future landscape of hepatitis C research - Basic, translational and clinical perspectives.

Moradpour D, Grakoui A, Manns MP

J Hepatol. 2016 Oct;65(1 Suppl):S143-S155

Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.

Vandenbulcke H, Moreno C, Colle I, Knebel JF, Francque S, Sersté T, George C, de Galocsy C, Laleman W, Delwaide J, Orlent H, Lasser L, Trépo E, Van Vlierberghe H, Michielsen P, van Gossum M, de Vos M, Marot A, Doerig C, Henrion J, Deltenre P

J Hepatol. 2016 Sep;65(3):543-51

Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?

Vaucher C, Maillard MH, Froehlich F, Burnand B, Michetti P, Pittet V

Scand J Gastroenterol. 2016 Sep;51(9):1056-61

Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach.

Giudici F, Bertisch B, Negro F, Stirnimann G, Müllhaupt B, Moradpour D, Cerny A, Keiser O, Swiss Hepatitis C Cohort Study.

J Viral Hepat. 2016 Sep;23(9):697-707

Inflammation, immunity, and vaccines for Helicobacter pylori infection.

Velin D, Straubinger K, Gerhard M

Helicobacter. 2016 Sep;21 Suppl 1:26-9

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.

Oussalah A, Avogbe PH, Guyot E, Chery C, Guéant-Rodriguez RM, Ganne-Carrié N, Cobat A, Moradpour D, Nalpas B, Negro F, Poynard T, Pol S, Bochud PY, Abel L, Jeulin H, Schvoerer E, Chabi N, Amouzou E, Sanni A, Barraud H, Rouyer P, Josse T, Goffinet L, Jouve

Oncotarget. 2017 Sep 8;8(38):62842-62857

Hepatitis E virus infection as a direct cause of neuralgic amyotrophy.

Silva M, Wicki B, Tsouni P, Cunningham S, Doerig C, Zanetti G, Aubert V, Sahli R, Moradpour D, Kuntzer T

Muscle Nerve. 2016 Aug;54(2):325-7

HIV-Positive-to-HIV-Positive Liver Transplantation.

Calmy A, van Delden C, Giostra E, Junet C, Rubbia Brandt L, Yerly S, Chave JP, Samer C, Elkrief L, Vionnet J, Berney T, Swiss HIV and Swiss Transplant Cohort Studies.

Am J Transplant. 2016 Aug;16(8):2473-8

Preventing Overheating: Tight Control of Gut Innate Immunity in Health and Disease.

Begka C, Velin D, Maillard MH

Inflamm Bowel Dis 2016 Jul, 22:1723-36

Insulin resistance is associated with esophageal varices in alcoholic liver disease patients.

Degré D, Gustot T, Gerkens A, Boon N, Schreiber J, Lepida A, Sersté T, Deltenre P, Devière J, Trépo E, Moreno C

Eur J Gastroenterol Hepatol. 2016 Jul;28(7):792-6

Update on hepatitis E virology: Implications for clinical practice.

Debing Y, Moradpour D, Neyts J, Gouttenoire J

J Hepatol. 2016 Jul;65(1):200-212

Non-Hodgkin lymphoma and idiopathic inflammatory cardiomyopathy.

Rutz T, Prior JO, Vionnet J, Pruvot E

Eur Heart J. 2016 Jun 14;37(23):1859

Use of VacA as a Vaccine Antigen.

Moyat M, Velin D

Toxins (Basel). 2016 Jun 8;8(6)

Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease.

Mikocka-Walus A, Pittet V, Rossel JB, von Känel R, Swiss IBD Cohort Study Group.

Clin Gastroenterol Hepatol. 2016 Jun;14(6):829-835.e1

Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus.

Fogeron ML, Jirasko V, Penzel S, Paul D, Montserret R, Danis C, Lacabanne D, Badillo A, Gouttenoire J, Moradpour D, Bartenschlager R, Penin F, Meier BH, Böckmann A

J Biomol NMR. 2016 Jun;65(2):87-98

Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations.

Bertisch B, Giudici F, Negro F, Moradpour D, Müllhaupt B, Moriggia A, Estill J, Keiser O, Swiss Hepatitis C Cohort Study.

PLoS One. 2016;11(5):e0155464

A mouse model for hepatitis E virus infection.

Gouttenoire J, Moradpour D

J Hepatol. 2016 May;64(5):1003-1005

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5).

Mallet V, van Bömmel F, Doerig C, Pischke S, Hermine O, Locasciulli A, Cordonnier C, Berg T, Moradpour D, Wedemeyer H, Ljungman P, ECIL-5.

Lancet Infect Dis. 2016 May;16(5):606-617

Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania.

Winter A, Letang E, Vedastus Kalinjuma A, Kimera N, Ntamatungiro A, Glass T, Moradpour D, Sahli R, Le Gal F, Furrer H, Wandeler G, KIULARCO Study Group.

Int J Infect Dis. 2016 May;46:8-10

Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

Moreno C, Deltenre P, Senterre C, Louvet A, Gustot T, Bastens B, Hittelet A, Piquet MA, Laleman W, Orlent H, Lasser L, Sersté T, Starkel P, De Koninck X, Negrin Dastis S, Delwaide J, Colle I, de Galocsy C, Francque S, Langlet P, Putzeys V, Reynaert H, Deg

Gastroenterology. 2016 Apr;150(4):903-10.e8

Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?

Pittet V, Vaucher C, Maillard MH, Girardin M, de Saussure P, Burnand B, Rogler G, Michetti P

PLoS One. 2016;11(3):e0150620

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis.

Safroneeva E, Straumann A, Coslovsky M, Zwahlen M, Kuehni CE, Panczak R, Haas NA, Alexander JA, Dellon ES, Gonsalves N, Hirano I, Leung J, Bussmann C, Collins MH, Newbury RO, De Petris G, Smyrk TC, Woosley JT, Yan P, Yang GY, Romero Y, Katzka DA, Furuta G

Gastroenterology. 2016 Mar;150(3):581-590.e4

Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?

Mueller R, Ziade F, Pittet V, Fournier N, Ezri J, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A, Swiss IBD Cohort Study.

J Crohns Colitis. 2016 Mar;10(3):269-76

Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists.

Vavricka SR, Sulz MC, Degen L, Rechner R, Manz M, Biedermann L, Beglinger C, Peter S, Safroneeva E, Rogler G, Schoepfer AM

Endoscopy. 2016 Mar;48(3):256-62

Uncontrolled hepatitis delta virus infection after initial suppression on tenofovir in a HIV/HBV-coinfected patient.

Béguelin C, Vazquez M, Moradpour D, Sahli R, Suter F, Rauch A, Wandeler G

AIDS. 2016 Jan 28;30(3):530-2

Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.

Dao Thi VL, Debing Y, Wu X, Rice CM, Neyts J, Moradpour D, Gouttenoire J

Gastroenterology. 2016 Jan;150(1):82-85.e4

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs.

Arain A, Bourgeois S, de Galocsy C, Henrion J, Deltenre P, d'Heygere F, George C, Bastens B, Van Overbeke L, Verrando R, Bruckers L, Mathei C, Buntinx F, Van Vlierberghe H, Francque S, Laleman W, Moreno C, Janssens F, Nevens F, Robaeys G

J Med Virol. 2016 Jan;88(1):94-9

Gastro-entérite à éosinophiles

Burgmann K, Brunel C, Sempoux C, Ribi C, Godat S, Moradpour D, Schoepfer AM

Rev Med Suisse 2016;12:1419-1423

Transplantation fécale : les faits et les espoirs démesurés ?

Frossard J-L et Moradpour D

Rev Med Suisse 2016;12:1403-1404

Amyloïdose héréditaire à transthyrétine

Vionnet J, Pascual M, Kuntzer T, Yerly P, Moradpour D

Rev Med Suisse 2016;12:1434-144

Hépatite E

Béguelin C, Fraga M, Wandeler G, Sahli R, Rauch A, Moradpour D.

Forum Med Suisse 2016;16:510-4

2015

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.

Buch S, Stickel F, Trépo E, Way M, Herrmann A, Nischalke HD, Brosch M, Rosendahl J, Berg T, Ridinger M, Rietschel M, McQuillin A, Frank J, Kiefer F, Schreiber S, Lieb W, Soyka M, Semmo N, Aigner E, Datz C, Schmelz R, Brückner S, Zeissig S, Stephan AM, Wod

Nat Genet. 2015 Dec;47(12):1443-8

Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study.

Giriens B, Yan P, Safroneeva E, Zwahlen M, Reinhard A, Nydegger A, Vavricka S, Sempoux C, Straumann A, Schoepfer AM

Allergy. 2015 Dec;70(12):1633-9

Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding.

Marot A, Trépo E, Doerig C, Moreno C, Moradpour D, Deltenre P

Aliment Pharmacol Ther. 2015 Dec;42(11-12):1250-60

Role of Inflammatory Monocytes in Vaccine-Induced Reduction of Helicobacter felis Infection.

Moyat M, Mack M, Bouzourene H, Velin D

Infect Immun. 2015 Nov;83(11):4217-28

Impact of common risk factors of fibrosis progression in chronic hepatitis C.

Rüeger S, Bochud PY, Dufour JF, Müllhaupt B, Semela D, Heim MH, Moradpour D, Cerny A, Malinverni R, Booth DR, Suppiah V, George J, Argiro L, Halfon P, Bourlière M, Talal AH, Jacobson IM, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Negro F

Gut. 2015 Oct;64(10):1605-15

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity.

Safroneeva E, Coslovsky M, Kuehni CE, Zwahlen M, Haas NA, Panczak R, Taft TH, Hirano I, Dellon ES, Gonsalves N, Leung J, Bussmann C, Woosley JT, Yan P, Romero Y, Furuta GT, Gupta SK, Aceves SS, Chehade M, Straumann A, Schoepfer AM, International EEsAI Stu

Aliment Pharmacol Ther. 2015 Oct;42(8):1000-10

[Factors influencing development and progression of alcoholic liver disease].

Abdelrahman K, Marot A, Deltenre P

Rev Med Suisse. 2015 Sep 2;11(484):1604-7

[Hepatitis C: 25 years of progress with still major challenges].

Moradpour D, Frossard JL

Rev Med Suisse. 2015 Sep 2;11(484):1579-80

Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials.

Deltenre P, Trépo E, Rudler M, Monescillo A, Fraga M, Denys A, Doerig C, Fournier N, Moreno C, Moradpour D, Bureau C, Thabut D

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):e1-9

Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients.

Safroneeva E, Vavricka S, Fournier N, Seibold F, Mottet C, Nydegger A, Ezri J, Straumann A, Rogler G, Schoepfer AM, Swiss IBD Cohort Study Group.

Aliment Pharmacol Ther. 2015 Sep;42(5):540-8

Extraintestinal Manifestations of Inflammatory Bowel Disease.

Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G

Inflamm Bowel Dis. 2015 Aug;21(8):1982-92

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.

Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, French LE, Safroneeva E, Fournier N, Straumann A, Froehlich F, Fried M, Michetti P, Seibold F, Lakatos PL, Peyrin-Biroulet L, Schoepfer AM

Inflamm Bowel Dis. 2015 Aug;21(8):1794-800

The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis.

Sersté T, Njimi H, Degré D, Deltenre P, Schreiber J, Lepida A, Trépo E, Gustot T, Moreno C

Liver Int. 2015 Aug;35(8):1974-82

The 'Red Flag Instrument' for Early Detection of Crohn's Disease: Is it ready for Clinical Practice?

Schoepfer A, Vavricka S

J Crohns Colitis. 2015 Aug;9(8):597-8

[Surgical treatment of gastroesophageal diseases].

Winiker M, Schoepfer A, Demartines N, Allemann P

Rev Med Suisse. 2015 Jun 17;11(479):1351-6

Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?

Schoepfer A, Reinisch W

Am J Gastroenterol. 2015 Jun;110(6):888-90

Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study.

Safroneeva E, Vavricka SR, Fournier N, Straumann A, Rogler G, Schoepfer AM

Inflamm Bowel Dis. 2015 Jun;21(6):1348-58

Studies on the epidemiology of hepatitis B and C virus infections are still needed.

Deltenre P

J Hepatol. 2015 Jun;62(6):1225-7

Serial fecal calprotectin measurements to detect endoscopic recurrence in postoperative Crohn's disease: is colonoscopic surveillance no longer needed?

Schoepfer AM, Lewis JD

Gastroenterology. 2015 May;148(5):889-92

[Hepatitis C: current therapy].

Moradpour D, Müllhaupt B

Rev Med Suisse. 2015 Apr 22;11(471):902-6

[Hepatitis C: epidemiology natural course and diagnosis].

Moradpour D, Müllhaupt B

Rev Med Suisse. 2015 Apr 22;11(471):896-901

[Hepatitis C: patient information].

Müllhaupt B, Moradpour D

Rev Med Suisse. 2015 Apr 22;11(471):907-8

Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.

Welsch C, Haselow K, Gouttenoire J, Schneider M, Morikawa K, Martinez Y, Susser S, Sarrazin C, Zeuzem S, Antes I, Moradpour D, Lange CM

J Hepatol. 2015 Apr;62(4):779-84

Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.

Vionnet J, Pascual M, Chtioui H, Giostra E, Majno PE, Decosterd LA, Moradpour D

BMC Gastroenterol. 2015 Mar 26;15:38

Epithelial NAIPs protect against colonic tumorigenesis.

Allam R, Maillard MH, Tardivel A, Chennupati V, Bega H, Yu CW, Velin D, Schneider P, Maslowski KM

J Exp Med. 2015 Mar 9;212(3):369-83

How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?

Schoepfer AM, Panczak R, Zwahlen M, Kuehni CE, Coslovsky M, Maurer E, Haas NA, Alexander JA, Dellon ES, Gonsalves N, Hirano I, Leung J, Bussmann C, Collins MH, Newbury RO, De Petris G, Smyrk TC, Woosley JT, Yan P, Yang GY, Romero Y, Katzka DA, Furuta GT,

Am J Gastroenterol. 2015 Mar;110(3):402-14

Stenting after severe iatrogenic submucosal dissection in a patient with newly diagnosed eosinophilic esophagitis.

Sawatzki M, Schoepfer A, Borovicka J, Meyenberger C, Frei R

Gastrointest Endosc. 2015;81(6):1499-501

Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort study.

Multone E, Vader JP, Mottet C, Schoepfer A, Fournier N, Burnand B, Michetti P, Pittet V

Scand J Gastroenterol. 2015;50(11):1348-56

2014

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Terczyńska-Dyla E, Bibert S, Duong FH, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Malinverni R, Mangia A, Moradpour D, Müllhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group., Heim MH, Bochud

Nat Commun. 2014 Dec 23;5:5699

Addressing current treatment challenges in Crohn's disease in real life: a physician's survey.

Vavricka SR, Radivojevic S, Manser CN, Frei P, Burri E, Fried M, Schoepfer A, Peyrin-Biroulet L, Michetti P, Rogler G, Biedermann L

Dig Liver Dis. 2014 Dec;46(12):1066-71

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Schoepfer AM, Straumann A, Panczak R, Coslovsky M, Kuehni CE, Maurer E, Haas NA, Romero Y, Hirano I, Alexander JA, Gonsalves N, Furuta GT, Dellon ES, Leung J, Collins MH, Bussmann C, Netzer P, Gupta SK, Aceves SS, Chehade M, Moawad FJ, Enders FT, Yost KJ,

Gastroenterology. 2014 Dec;147(6):1255-66.e21

Aminoterminal amphipathic α-helix AH1 of hepatitis C virus nonstructural protein 4B possesses a dual role in RNA replication and virus production.

Gouttenoire J, Montserret R, Paul D, Castillo R, Meister S, Bartenschlager R, Penin F, Moradpour D

PLoS Pathog. 2014 Oct;10(10):e1004501

The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.

Protic M, Seibold F, Schoepfer A, Radojicic Z, Juillerat P, Bojic D, Mwinyi J, Mottet C, Jojic N, Beglinger C, Vavricka S, Rogler G, Frei P

J Crohns Colitis. 2014 Nov;8(11):1427-37

Hepatitis C virus infection and kidney transplantation in 2014: what's new?

Baid-Agrawal S, Pascual M, Moradpour D, Somasundaram R, Muche M

Am J Transplant. 2014 Oct;14(10):2206-20

The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease.

Schoepfer AM, Bortolotti M, Pittet V, Mottet C, Gonvers JJ, Reich O, Fournier N, Vader JP, Burnand B, Michetti P, Froehlich F

Aliment Pharmacol Ther. 2014 Oct;40(8):930-7

Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort.

Hiroz P, Vavricka SR, Fournier N, Safroneeva E, Pittet V, Rogler G, Schoepfer AM, Swiss Inflammatory Bowel Diseases Cohort Study Group.

Scand J Gastroenterol. 2014 Oct;49(10):1207-18

Clinical significance of the CCR5delta32 allele in hepatitis C.

Morard I, Clément S, Calmy A, Mangia A, Cerny A, De Gottardi A, Gorgievski M, Heim M, Malinverni R, Moradpour D, Müllhaupt B, Semela D, Pascarella S, Bochud PY, Negro F, Swiss Hepatitis C Cohort Study Group.

PLoS One. 2014;9(9):e106424

[Microscopic colitis: update 2014].

Burgmann K, Fraga M, Schoepfer AM, Yun P

Rev Med Suisse. 2014 Sep 3;10(440):1586, 1588-90

[New hepatitis C treatments: pharmacological considerations and potential for drug interactions].

Chtioui H, Buclin T, Moradpour D

Rev Med Suisse. 2014 Sep 3;10(440):1600-4, 1606

[Hepatic encephalopathy: recent developments].

Deltenre P, Moradpour D

Rev Med Suisse. 2014 Sep 3;10(440):1612, 1614-6

[Coffee and the pancreas: a half life of medical truth].

Frossard JL, Moradpour D

Rev Med Suisse. 2014 Sep 3;10(440):1579

Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.

Kuchen T, Straumann A, Safroneeva E, Romero Y, Bussmann C, Vavricka S, Netzer P, Reinhard A, Portmann S, Schoepfer AM

Allergy. 2014 Sep;69(9):1248-54

Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.

Schaffer T, Schoepfer AM, Seibold F, Swiss IBD Cohort Study Group.

J Crohns Colitis. 2014 Sep;8(9):1125-32

Risk factors for repetitive ileocolic resection in patients with Crohn's disease: results of an observational cohort study.

Manser CN, Frei P, Grandinetti T, Biedermann L, Mwinyi J, Vavricka SR, Schoepfer A, Fried M, Rogler G, Investigators of the Swiss IBD Cohort Study.

Inflamm Bowel Dis. 2014 Sep;20(9):1548-54

Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis.

Boettler T, Moradpour D, Thimme R, Zoulim F

J Hepatol. 2014 Sep;61(3):696-705

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy.

Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, Cardona V, Dubois A, duToit G, Eigenmann P, Fernandez Rivas M, Halken S, Hickstein L, Høst A, Knol E, Lack G, Marchisotto MJ, Niggemann B, Nwaru BI, Papadopoulos NG, Pouls

Allergy. 2014 Aug;69(8):1008-25

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis.

Maillard MH, Bortolotti M, Vader JP, Mottet C, Schoepfer A, Gonvers JJ, Burnand B, Froehlich F, Michetti P, Pittet V, Swiss IBD Cohort Study Group.

J Crohns Colitis. 2014 Aug;8(8):825-34

Update on basic and clinical aspects of eosinophilic oesophagitis.

Straumann A, Schoepfer A

Gut. 2014 Aug;63(8):1355-63

Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index.

Hoggart CJ, Venturini G, Mangino M, Gomez F, Ascari G, Zhao JH, Teumer A, Winkler TW, Tšernikova N, Luan J, Mihailov E, Ehret GB, Zhang W, Lamparter D, Esko T, Macé A, Rüeger S, Bochud PY, Barcella M, Dauvilliers Y, Benyamin B, Evans DM, Hayward C, Lopez

PLoS Genet. 2014 Jul;10(7):e1004508

GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.

Masin M, Vazquez J, Rossi S, Groeneveld S, Samson N, Schwalie PC, Deplancke B, Frawley LE, Gouttenoire J, Moradpour D, Oliver TG, Meylan E

Cancer Metab. 2014;2:11

Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort.

Violi NV, Schoepfer AM, Fournier N, Guiu B, Bize P, Denys A, Swiss Inflammatory Bowel Disease Cohort Study Group.

AJR Am J Roentgenol. 2014 Jul;203(1):62-9

NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies.

Boukadida C, Marnata C, Montserret R, Cohen L, Blumen B, Gouttenoire J, Moradpour D, Penin F, Martin A

J Virol. 2014 Jul;88(13):7426-44

Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).

Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y

J Hepatol. 2014 Jul;61(1):7-14

Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α.

Lange CM, Gouttenoire J, Duong FH, Morikawa K, Heim MH, Moradpour D

J Immunol. 2014 Jun 15;192(12):6037-44

Protective role of amantadine in mitochondrial dysfunction and oxidative stress mediated by hepatitis C virus protein expression.

Quarato G, Scrima R, Ripoli M, Agriesti F, Moradpour D, Capitanio N, Piccoli C

Biochem Pharmacol. 2014 Jun 15;89(4):545-56

Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients.

Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, Burnand B, Vader JP, Swiss IBD Cohort Study Group.

Scand J Gastroenterol. 2014 Jun;49(6):662-73

Eosinophilic esophagitis: overview of clinical management.

Schoepfer AM, Hirano I, Katzka DA

Gastroenterol Clin North Am. 2014 Jun;43(2):329-44

Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.

Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D

J Hepatol. 2014 Jun;60(6):1151-7

Determinants for membrane association of the hepatitis C virus NS2 protease domain.

Lange CM, Bellecave P, Dao Thi VL, Tran HT, Penin F, Moradpour D, Gouttenoire J

J Virol. 2014 Jun;88(11):6519-23

Association between the PNPLA3 (rs738409 C&gt;G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.

Trépo E, Nahon P, Bontempi G, Valenti L, Falleti E, Nischalke HD, Hamza S, Corradini SG, Burza MA, Guyot E, Donati B, Spengler U, Hillon P, Toniutto P, Henrion J, Franchimont D, Devière J, Mathurin P, Moreno C, Romeo S, Deltenre P

Hepatology. 2014 Jun;59(6):2170-7

Late biliary complications in human alveolar echinococcosis are associated with high mortality.

Frei P, Misselwitz B, Prakash MK, Schoepfer AM, Prinz Vavricka BM, Müllhaupt B, Fried M, Lehmann K, Ammann RW, Vavricka SR

World J Gastroenterol. 2014 May 21;20(19):5881-8

Immune responses to Helicobacter pylori infection.

Moyat M, Velin D

World J Gastroenterol. 2014 May 21;20(19):5583-93

[Clostridium difficile infections: update on new European recommendations].

Tissot F, Maillard MH

Rev Med Suisse. 2014 Apr 23;10(427):913-6, 918-9

[Food allergy or food intolerance?].

Maître S, Maniu CM, Buss G, Maillard MH, Spertini F, Ribi C

Rev Med Suisse. 2014 Apr 16;10(426):846-50, 852-3

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients.

Frei P, Leucht AK, Held U, Kofmehl R, Manser CN, Schmitt J, Mertens J, Rau M, Baur K, Gerlach T, Negro F, Heim M, Moradpour D, Cerny A, Dufour JF, Müllhaupt B, Geier A, Swiss Hepatitis C Cohort Study Group.

Liver Int. 2014 Apr;34(4):551-7

Commentary: the proton pump inhibitor test - does it have a role in eosinophilic oesophagitis? Authors' reply.

Moawad FJ, Schoepfer AM

Aliment Pharmacol Ther. 2014 Apr;39(8):897-8

[Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)].

Thimme R, Heim M, Baumert TF, Nassal M, Moradpour D

Dtsch Med Wochenschr. 2014 Apr;139(15):778-82

Toll-interacting protein modulates colitis susceptibility in mice.

Maillard MH, Bega H, Uhlig HH, Barnich N, Grandjean T, Chamaillard M, Michetti P, Velin D

Inflamm Bowel Dis. 2014 Apr;20(4):660-70

[Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)].

Thimme R, Heim M, Baumert TF, Nassal M, Moradpour D

Dtsch Med Wochenschr. 2014 Mar;139(13):655-9

High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients.

Vavricka SR, Rogler G, Maetzler S, Misselwitz B, Safroneeva E, Frei P, Manser CN, Biedermann L, Fried M, Higgins P, Wojtal KA, Schoepfer AM

J Crohns Colitis. 2014 Mar;8(3):191-9

Steroid use in Crohn's disease.

Vavricka SR, Schoepfer AM, Scharl M, Rogler G

Drugs. 2014 Mar;74(3):313-24

Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.

Moawad FJ, Schoepfer AM, Safroneeva E, Ally MR, Chen YJ, Maydonovitch CL, Wong RK

Aliment Pharmacol Ther. 2014 Mar;39(6):603-8

Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.

Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, Canva V, Louvet A, Deltenre P, Boleslawski E, Truant S, Pruvot FR, Dharancy S

Dig Liver Dis. 2014 Feb;46(2):157-63

Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease.

Morikawa K, Gouttenoire J, Hernandez C, Dao Thi VL, Tran HT, Lange CM, Dill MT, Heim MH, Donzé O, Penin F, Quadroni M, Moradpour D

Hepatology. 2014 Feb;59(2):423-33

[Highlights in gastroenterology and hepatology 2013].

Hessler R, Godat S, Fraga M, Burgmann K, Doerig C, Deltenre P, Schoepfer A

Rev Med Suisse. 2014 Jan 15;10(412-413):41-4

Treatment of eosinophilic esophagitis by dilation.

Schoepfer A

Dig Dis. 2014;32(1-2):130-3

In vitro and in vivo repair activities of undifferentiated and classically and alternatively activated macrophages.

Enderlin Vaz da Silva Z, Lehr HA, Velin D

Pathobiology. 2014;81(2):86-93

Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations.

Sauter B, Beglinger C, Girardin M, Macpherson A, Michetti P, Schoepfer A, Seibold F, Vavricka SR, Rogler G

Digestion. 2014;89(4):299-309

Critical role of the GM-CSF signaling pathway in macrophage pro-repair activities.

Bernasconi E, D'Angelo F, Michetti P, Velin D

Pathobiology. 2014;81(4):183-9

Activity assessment of eosinophilic esophagitis.

Schoepfer A, Safroneeva E

Dig Dis. 2014;32(1-2):98-101

2013

Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon HU, Straumann A

Gastroenterology. 2013 Dec;145(6):1230-6.e1-2

Periodontitis and gingivitis in inflammatory bowel disease: a case-control study.

Vavricka SR, Manser CN, Hediger S, Vögelin M, Scharl M, Biedermann L, Rogler S, Seibold F, Sanderink R, Attin T, Schoepfer A, Fried M, Rogler G, Frei P

Inflamm Bowel Dis. 2013 Dec;19(13):2768-77

The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method.

Reinisch W, Chowers Y, Danese S, Dignass A, Gomollón F, Nielsen OH, Lakatos PL, Lees CW, Lindgren S, Lukas M, Mantzaris GJ, Michetti P, Moum B, Peyrin-Biroulet L, Toruner M, van der Woude J, Weiss G, Stoevelaar H

Aliment Pharmacol Ther. 2013 Nov;38(9):1109-18

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.

Pittet V, Froehlich F, Maillard MH, Mottet C, Gonvers JJ, Felley C, Vader JP, Burnand B, Michetti P, Schoepfer A, EPACT-II Update Panellists.

J Crohns Colitis. 2013 Nov;7(10):820-6

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate.

Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, Peyrin-Biroulet L, Michetti P, Rogler G, Vavricka SR, IBD Cohort Study Group.

Am J Gastroenterol. 2013 Nov;108(11):1744-53; quiz 1754

The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy.

Windsor A, Michetti P, Bemelman W, Ghosh S

Inflamm Bowel Dis. 2013 Nov;19(12):2695-703

Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.

Burgmann K, Fatio S, Jordi B, Rutishauser J

Swiss Med Wkly. 2013;143:w13871

Macrophages promote epithelial repair through hepatocyte growth factor secretion.

D'Angelo F, Bernasconi E, Schäfer M, Moyat M, Michetti P, Maillard MH, Velin D

Clin Exp Immunol. 2013 Oct;174(1):60-72

Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.

de Vos M, De Vroey B, Garcia BG, Roy C, Kidd F, Henrion J, Deltenre P

Liver Int. 2013 Oct;33(9):1316-23

[Progress and new challenges in hepatitis C].

Moradpour D, Frossard JL

Rev Med Suisse. 2013 Sep 4;9(396):1563-4

[An update on hepatitis E].

Hiroz P, Gouttenoire J, Dao Thi VL, Sahli R, Telenti A, Moradpour D, Doerig C

Rev Med Suisse. 2013 Sep 4;9(396):1594, 1596-8

[An update on celiac disease].

Godat S, Velin D, Aubert V, Nydegger A, Schoepfer AM, Maillard MH

Rev Med Suisse. 2013 Sep 4;9(396):1584-9

[Radiofrequency ablation for Barret's esophagus].

Fraga M, Doerig C, Dorta G, Nichita C

Rev Med Suisse. 2013 Sep 4;9(396):1572-6

Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.

Ho E, Deltenre P, Nkuize M, Delwaide J, Colle I, Michielsen P, Belgian Association for the Study of the Liver.

J Med Virol. 2013 Sep;85(9):1513-7

Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.

Lange CM, Bibert S, Dufour JF, Cellerai C, Cerny A, Heim MH, Kaiser L, Malinverni R, Müllhaupt B, Negro F, Semela D, Moradpour D, Kutalik Z, Bochud PY, Swiss Hepatitis C Cohort Study Group.

J Hepatol. 2013 Sep;59(3):504-9

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women.

Pedersen N, Bortoli A, Duricova D, D Inca R, Panelli MR, Gisbert JP, Zoli G, López-Sanromán A, Castiglione F, Riegler G, Annese V, Gionchetti P, Prada A, Pont ED, Timmer A, Felley C, Shuhaibar M, Tsianos EV, Dejaco C, Baert FJ, Jess T, Lebech M, Hommes DW

Aliment Pharmacol Ther. 2013 Sep;38(5):501-12

Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients.

Buyse S, Roque-Afonso AM, Vaghefi P, Gigou M, Dussaix E, Duclos-Vallée JC, Samuel D, Guettier C

Am J Clin Pathol. 2013 Sep;140(3):403-9

Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion.

Rogler G, Aldeguer X, Kruis W, Lasson A, Mittmann U, Nally K, Peyrin-Biroulet L, Schoepfer A, Vatn M, Vavricka S, Logan R

J Crohns Colitis. 2013 Sep;7(8):670-7

Vedolizumab as induction and maintenance therapy for Crohn's disease.

Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A, GEMINI 2 Study Group.

N Engl J Med. 2013 Aug 22;369(8):711-21

Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.

Trépo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C, Gustot T, Degré D, Vercruysse V, Deltenre P, Verset L, Gulbis B, Franchimont D, Devière J, Lemmers A, Moreno C

J Hepatol. 2013 Aug;59(2):344-50

Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study.

Sulz MC, Siebert U, Arvandi M, Gothe RM, Wurm J, von Känel R, Vavricka SR, Meyenberger C, Sagmeister M, Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):790-7

Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1.

Stickel F, Worni M, Pache I, Moradpour D, Helbling B, Borovicka J, Gerlach TJ

Am J Gastroenterol. 2013 Jul;108(7):1176-8

Multiplex liquid chromatography-tandem mass spectrometry assay for simultaneous therapeutic drug monitoring of ribavirin, boceprevir, and telaprevir.

Aouri M, Moradpour D, Cavassini M, Mercier T, Buclin T, Csajka C, Telenti A, Rauch A, Decosterd LA

Antimicrob Agents Chemother. 2013 Jul;57(7):3147-58

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, Duong FH, Gerlach T, Malinverni R, Moradpour D, Negro F, Müllhaupt B, Bochud PY, Swiss Hepatitis C Cohort Study.

J Exp Med. 2013 Jun 3;210(6):1109-16

Effects of an interleukin-15 antagonist on systemic and skeletal alterations in mice with DSS-induced colitis.

Brounais-Le Royer B, Pierroz DD, Velin D, Frossard C, Zheng XX, Lehr HA, Ferrari-Lacraz S, Ferrari SL

Am J Pathol. 2013 Jun;182(6):2155-67

Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.

Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour JF, Gorgievski-Hrisoho M, Heim MH, Malinverni R, Müllhaupt B, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochu

PLoS One. 2013;8(5):e64053

Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection.

Fretz R, Negro F, Bruggmann P, Lavanchy D, De Gottardi A, Pache I, Masserey Spicher V, Cerny A

Swiss Med Wkly. 2013;143:w13793

An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.

Schnegg A, Bürgisser P, André C, Kenfak-Foguena A, Canellini G, Moradpour D, Abravanel F, Izopet J, Cavassini M, Darling KE

PLoS One. 2013;8(5):e62980

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

De Vroey B, Moreno C, Laleman W, van Gossum M, Colle I, de Galocsy C, Langlet P, Robaeys G, Orlent H, Michielsen P, Delwaide J, Reynaert H, D'Heygere F, Sprengers D, Bourgeois S, Assene C, Vos B, Brenard R, Adler M, Henrion J, Deltenre P

Eur J Gastroenterol Hepatol. 2013 May;25(5):613-9

[Allergy to radiographic contrast media].

Vionnet J, Petitpierre S, Fumeaux A, Meuli R, Spertini F, Comte D

Rev Med Suisse. 2013 Apr 17;9(382):812-8

Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.

Perreau M, Rozot V, Welles HC, Belluti-Enders F, Vigano S, Maillard M, Dorta G, Mazza-Stalder J, Bart PA, Roger T, Calandra T, Nicod L, Harari A

Eur J Immunol. 2013 Apr;43(4):939-48

Methodological assessment of HCC literature.

Daniele G, Costa N, Lorusso V, Costa-Maia J, Pache I, Pirisi M

Ann Oncol. 2013 Apr;24 Suppl 2:ii6-14

Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection.

Rau M, Stickel F, Russmann S, Manser CN, Becker PP, Weisskopf M, Schmitt J, Dill MT, Dufour JF, Moradpour D, Semela D, Müllhaupt B, Geier A, Swiss Hepatitis C Cohort Study Group (SCCS).

J Hepatol. 2013 Apr;58(4):669-75

Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.

Esser-Nobis K, Romero-Brey I, Ganten TM, Gouttenoire J, Harak C, Klein R, Schemmer P, Binder M, Schnitzler P, Moradpour D, Bartenschlager R, Polyak SJ, Stremmel W, Penin F, Eisenbach C, Lohmann V

Hepatology. 2013 Mar;57(3):953-63

A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease.

Vavricka SR, Schoepfer AM, Safroneeva E, Rogler G, Schwenkglenks M, Achermann R

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):840-6

Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study.

Siebert U, Wurm J, Gothe RM, Arvandi M, Vavricka SR, von Känel R, Begré S, Sulz MC, Meyenberger C, Sagmeister M, Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):847-55

[Wilson's disease: programed wandering?].

Bersier M, Pache I

Rev Med Suisse. 2013 Feb 13;9(373):384-5

Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.

Schaffer T, Flogerzi B, Schoepfer AM, Seibold F, Müller S

J Crohns Colitis. 2013 Feb;7(1):e1-10

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

Schoepfer AM, Beglinger C, Straumann A, Safroneeva E, Romero Y, Armstrong D, Schmidt C, Trummler M, Pittet V, Vavricka SR

Inflamm Bowel Dis. 2013 Feb;19(2):332-41

Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease.

Pittet V, Rogler G, Michetti P, Fournier N, Vader JP, Schoepfer A, Mottet C, Burnand B, Froehlich F, Swiss Inflammatory Bowel Disease Cohort Study Group.

Digestion. 2013;87(3):212-21

Targeting mitochondria in the infection strategy of the hepatitis C virus.

Quarato G, Scrima R, Agriesti F, Moradpour D, Capitanio N, Piccoli C

Int J Biochem Cell Biol. 2013 Jan;45(1):156-66

Hepatitis C virus proteins: from structure to function.

Moradpour D, Penin F

Curr Top Microbiol Immunol. 2013;369:113-42

Schlaglicht Hepatologie: Wichtiges zur chronischen Hepatitis C.

Müllhaupt B and Moradpour D.

Schweiz Med Forum 2013;13:28-30

Ikterus. In: Siegenthalers Differenzialdiagnose. Innere Krankheiten - vom Symptom zur Diagnose.

Moradpour D und Blum HE.

Battegay E, Hrsg. 20. Auflage. Georg Thieme Verlag, Stuttgart - New York, 2013, pp. 752-791

Schmerzen im Bereich des Abdomens. In: Siegenthalers Differenzialdiagnose. Innere Krankheiten - vom Symptom zur Diagnose.

Moradpour D und Blum HE.

Battegay E, Hrsg. 20. Auflage. Georg Thieme Verlag, Stuttgart - New York, 2013, pp. 272-317.

Schmerzen im Bereich des Abdomens. In: Siegenthalers Differenzialdiagnose. Innere Krankheiten - vom Symptom zur Diagnose.

Moradpour D und Blum HE

Battegay E, Hrsg. 20. Auflage. Georg Thieme Verlag, Stuttgart - New York, 2013, pp. 272-317.

Ikterus. In: Siegenthalers Differenzialdiagnose. Innere Krankheiten - vom Symptom zur Diagnose.

Moradpour D und Blum HE

Battegay E, Hrsg. 20. Auflage. Georg Thieme Verlag, Stuttgart - New York, 2013, pp. 752-791

Anti-TNF therapy in the treatment of psoriasis in a patient with acute-on-chronic pancreatitis.

Clayton H, Flatz L, Vollenweider-Roten S, Schoepfer A, Gilliet M, Conrad C

Dermatology. 2013;227(3):193-6

2012

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.

Meyrat P, Safroneeva E, Schoepfer AM

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1084-93

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

Patin E, Kutalik Z, Guergnon J, Bibert S, Nalpas B, Jouanguy E, Munteanu M, Bousquet L, Argiro L, Halfon P, Boland A, Müllhaupt B, Semela D, Dufour JF, Heim MH, Moradpour D, Cerny A, Malinverni R, Hirsch H, Martinetti G, Suppiah V, Stewart G, Booth DR, Ge

Gastroenterology. 2012 Nov;143(5):1244-1252.e12

Colorectal polypectomy during insertion and withdrawal or only during withdrawal? A randomized controlled trial.

Wildi SM, Schoepfer AM, Vavricka SR, Fruehauf H, Safroneeva E, Wiegand N, Bauerfeind P, Fried M

Endoscopy. 2012 Nov;44(11):1019-23

Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Date T, Kato T, Kato J, Takahashi H, Morikawa K, Akazawa D, Murayama A, Tanaka-Kaneko K, Sata T, Tanaka Y, Mizokami M, Wakita T

J Virol. 2012 Oct;86(19):10805-20

[Gastrointestinal neuroendocrine tumors: pleomorphic and often ignored].

Maillard MH, Hiroz P, Wagner D, Prior J, Boubaker A, Pralong F, Dorta G, Nichita C

Rev Med Suisse. 2012 Sep 5;8(352):1658-63

[Alcoholic liver disease: another neglected disease?].

Hadengue A, Moradpour D

Rev Med Suisse. 2012 Sep 5;8(352):1643-4

[Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].

Fraga M, Godat S, Nydegger A, Moradpour D, Schoepfer AM

Rev Med Suisse. 2012 Sep 5;8(352):1669-70, 1672-3

[Management of ascites due to portal hypertension].

Godat S, Antonino AT, Dehlavi MA, Moradpour D, Doerig C

Rev Med Suisse. 2012 Sep 5;8(352):1665-8

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma.

Kuske L, Mensen A, Müllhaupt B, Negro F, Semela D, Moradpour D, Malé PJ, Heim MH, Malinverni R, Cerny A, Dufour JF, Swiss Hepatitis C Cohort Study.

Swiss Med Wkly. 2012;142:w13651

Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.

Kaech C, Pache I, Bürgisser P, Elzi L, Darling KE, Cavassini M

J Infect. 2012 Aug;65(2):157-64

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.

Girardin F, Daali Y, Gex-Fabry M, Rebsamen M, Roux-Lombard P, Cerny A, Bihl F, Binek J, Moradpour D, Negro F, Desmeules J, Swiss Hepatitis C Cohort Study Group.

J Viral Hepat. 2012 Aug;19(8):568-73

Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia.

Felley C, Bouzourene H, VanMelle MB, Hadengue A, Michetti P, Dorta G, Spahr L, Giostra E, Frossard JL

World J Gastroenterol. 2012 May 7;18(17):2076-83

The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction.

Quarato G, D'Aprile A, Gavillet B, Vuagniaux G, Moradpour D, Capitanio N, Piccoli C

Hepatology. 2012 May;55(5):1333-43

Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers.

Schoepfer AM, Vavricka S, Zahnd-Straumann N, Straumann A, Beglinger C

J Crohns Colitis. 2012 May;6(4):412-8

Replication and infectivity of a novel genotype 1b hepatitis C virus clone.

Date T, Morikawa K, Tanaka Y, Tanaka-Kaneko K, Sata T, Mizokami M, Wakita T

Microbiol Immunol. 2012 May;56(5):308-17

Lymphotropic hepatitis C virus has an interferon-resistant phenotype.

Inokuchi M, Ito T, Nozawa H, Miyashita M, Morikawa K, Uchikoshi M, Shimozuma Y, Arai J, Shimazaki T, Hiroishi K, Imawari M

J Viral Hepat. 2012 Apr;19(4):254-62

Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

Rieder F, Karrasch T, Ben-Horin S, Schirbel A, Ehehalt R, Wehkamp J, de Haar C, Velin D, Latella G, Scaldaferri F, Rogler G, Higgins P, Sans M

J Crohns Colitis. 2012 Apr;6(3):373-85

Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.

Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, Dufour JF, Gerlach TJ, Heim MH, Malinverni R, Müllhaupt B, Negro F, Moradpour D, Bochud PY, Swiss Hepatitis C Cohort Study Group.

Hepatology. 2012 Apr;55(4):1038-47

Pediatric and adult eosinophilic esophagitis: similarities and differences.

Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I, Schoepfer AM, Simon D, Simon HU

Allergy. 2012 Apr;67(4):477-90

[Lipid-lowering treatment and liver dysfunction].

Gencer B, Moradpour D, Rodondi N

Rev Med Suisse. 2012 Mar 7;8(331):507-8, 510-2

Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.

Vavricka SR, Spigaglia SM, Rogler G, Pittet V, Michetti P, Felley C, Mottet C, Braegger CP, Rogler D, Straumann A, Bauerfeind P, Fried M, Schoepfer AM, Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2012 Mar;18(3):496-505

Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus.

Reinisch W, Van Assche G, Befrits R, Connell W, D'Haens G, Ghosh S, Michetti P, Ochsenkühn T, Panaccione R, Schreiber S, Silverberg MS, Sorrentino D, van der Woude CJ, Vermeire S, Panes J

J Crohns Colitis. 2012 Mar;6(2):248-58

EASL Clinical Practice Guidelines: Wilson's disease.

European Association for Study of Liver.

J Hepatol. 2012 Mar;56(3):671-85

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir.

Swiss Association for the Study of the Liver.

Swiss Med Wkly. 2012;142:w13516

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.

Bochud PY, Bibert S, Kutalik Z, Patin E, Guergnon J, Nalpas B, Goossens N, Kuske L, Müllhaupt B, Gerlach T, Heim MH, Moradpour D, Cerny A, Malinverni R, Regenass S, Dollenmaier G, Hirsch H, Martinetti G, Gorgiewski M, Bourlière M, Poynard T, Theodorou I,

Hepatology. 2012 Feb;55(2):384-94

Pathomechanistic characterization of two exonic L1CAM variants located in trans in an obligate carrier of X-linked hydrocephalus.

Marx M, Diestel S, Bozon M, Keglowich L, Drouot N, Bouché E, Frebourg T, Minz M, Saugier-Veber P, Castellani V, Schäfer MK

Neurogenetics. 2012 Feb;13(1):49-59

Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease.

Wenger S, Nikolaus S, Howaldt S, Bokemeyer B, Sturm A, Preiss JC, Schoepfer AM, Stallmach A, Schmidt C

J Crohns Colitis. 2012 Feb;6(1):21-8

Hépatite C - Avancées thérapeutiques.

Schneider MP, Genre N, Reymermier M, Bugnon O, Moradpour D.

pharmaJournal 11.2012, No 24, pp. 5-9

Hepatitis C virus proteins: from structure to function.

Moradpour D and Penin F.

Top Microbiol Immunol, in press

Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.

Manuel O, Baid-Agrawal S, Moradpour D, Pascual M

Contrib Nephrol. 2012;176:97-107

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report.

Feagan BG, Lémann M, Befrits R, Connell W, D'Haens G, Ghosh S, Michetti P, Ochsenkühn T, Panaccione R, Schreiber S, Silverberg M, Sorrentino D, van der Woude CJ, Vermeire S, Rutgeerts P

Inflamm Bowel Dis. 2012 Jan;18(1):152-60

Treatment of fibrostenotic and fistulizing Crohn's disease.

Schoepfer AM, Safroneeva E, Vavricka SR, Peyrin-Biroulet L, Mottet C

Digestion. 2012;86 Suppl 1:23-7

Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands.

Wölk B, Trautwein C, Büchele B, Kersting N, Blum HE, Rammensee HG, Cerny A, Stevanovic S, Moradpour D, Brass V

PLoS One. 2012;7(1):e29286

Mucosal healing with anti-TNF antibodies.

Chevaux JB, Vavricka SR, Rogler G, Lakatos PL, Schoepfer A, Peyrin-Biroulet L

Digestion. 2012;86 Suppl 1:16-22

Acute hepatitis with periportal confluent necrosis associated with human herpes virus 6 infection in liver transplant patients.

Buyse S, Roque AM, Vaghefi Parissa, Gigou M, Dussaix E, Duclos-Vallée JC, Samuel D, Guettier C.

Am J Clin Pathol, in press

First-line therapies in inflammatory bowel disease.

Girardin M, Manz M, Manser C, Biedermann L, Wanner R, Frei P, Safroneeva E, Mottet C, Rogler G, Schoepfer AM

Digestion. 2012;86 Suppl 1:6-10

Treatment of extraintestinal manifestations in inflammatory bowel disease.

Lakatos PL, Lakatos L, Kiss LS, Peyrin-Biroulet L, Schoepfer A, Vavricka S

Digestion. 2012;86 Suppl 1:28-35

A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.

Lange CM, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour JF, Geier A, Gerlach TJ, Heim MH, Malinverni R, Negro F, Regenass S, Badenhoop K, Bojunga J, Sarrazin C, Zeuzem S, Müller T, Berg T, Bochud PY, Moradpour D, Swiss Hepatitis C Cohort Study Group.

PLoS One. 2012;7(7):e40159

Schlaglicht Hepatologie: Wichtiges zur chronischen Hepatitis C.

Müllhaupt B and Moradpour D.

Schweiz Med Forum, in press

Therapy of steroid-resistant inflammatory bowel disease.

Manz M, Vavricka SR, Wanner R, Lakatos PL, Rogler G, Frei P, Safroneeva E, Schoepfer AM

Digestion. 2012;86 Suppl 1:11-5

2011

Viral genotype-specific role of PNPLA3, PPARG, MTTP and IL28B in hepatitis C virus-associated steatosis.

Cai T, Dufour J-F, Müllhaupt B, Gerlach T, Heim M, Moradpour D, Cerny A, Malinverni R, Kaddai V, Bochud M, Negro F, Bochud P-Y, on behalf of the Swiss Hepatitis C Cohort Study Group

J Hepatol 2011;55:529-535.

La transplantation hépatique.

Mentha G, Majno P, Morard I, Toso C, Moldovan B, Antonino A, Berney T, Morel P, Rubbia-Brandt L, Terraz S, Moradpour D, Hadengue A, Giostra E.

Rev Med Suisse 2011;7:192-193.

Is cold biopsy forceps resection of diminutive polyps really so inadequate ?

Froehlich F.

Endoscopy 2011;43:1015.

Oesophagite à éosinophiles : mise à jour 2011.

Godat S, Moradpour D, Schoepfer A.

Rev Med Suisse 2011;7:1678-1682.

La maladie de Wilson : un caméléon clinique auquel il faut penser.

Hiroz P, Antonino A, Doerig C, Pache I, Moradpour D.

Rev Med Suisse 2011;7:1690-1695.

IL28B polymorphisms in the treatment of chronic hepatitis C.

Lange CM, Zeuzem S.

J Hepatol 2011;55:692-701.

Lange CM, Zeuzem S.

Diacylglycerol acyltransferase-1 : a critical host factor for hepatitis C virus assembly and potential new drug target.

Gastroenterology 2011;140:1345-1347.

Immunosuppression in HCV-infected patients after renal transplantation.

Manuel O, Baid-Agrawal S, Moradpour D, Pascual M.

Contrib Nephrol 2011;176:97-107.

Treatment algorithm for moderate to severe ulcerative colitis.

Manz M, Michetti P, Seibold F, Rogler G, Beglinger C.

Swiss Med Weekly 2011:141:w13235.

Neues aus der Hepatologie [Editorial].

Moradpour D.

Ther Umsch 2011;68:173-174

Prévention du cancer colo-rectal.

Dehlavi A, Nichita C, Kessler Brondolo V, Bertolini D, Dorta G.

Rev Med Suisse 2011;7:1704-1709.

Virushepatitis.

Moradpour D and Blum HE.

Ther Umsch 2011;68:175-181.

L'ère qui s'ouvre dans la prise en charges des patients atteints d'hépatite C [Editorial].

Moradpour D and Hadengue A.

Rev Med Suisse 2011;7:1667-1668.

Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.

Morikawa K, Lange CM, Gouttenoire J, Brass V, Penin F, Moradpour D.

J Viral Hepat 2011;18:305-315.

Prise en charge de la cirrhose par le praticien.

Pache I.

Rev Med Suisse 2011;26;7:235-236.

[Topical therapy of ulcerative colitis].

Rogler G, Beglinger C, Mottet C, Seibold F, Gross V.

Praxis 2011;100:1413-1424.

Actualités en gastro-entérologie et hépatologie.

Schoepfer A, Pache I, Nichita C, Dorta G, Moradpour D.

Rev Med Suisse 2011;7:25-29.

Eosinophilic esophagitis - latest intelligence.

Schoepfer AM, Simon D, Straumann A.

Clin Exp Allergy 2011;41:630-639.

Production and characterization of HCV particles from serum-free culture.

Akazawa D, Morikawa K, Omi N, Takahashi H, Nakamura N, Mochizuki H, Date T, Ishii K, Suzuki T, Wakita T.

Vaccine 2011;29:4821-4828.

Panniculite pancréatique sur fistule pancréatico-portale.

Fournier J, Pouget R, Perrier P, Nichita C.

Schweiz Med Forum 2011;11:503-505.

Upper gastrointestinal bleeding: usefulness of prognostic scores.

Badel S, Dorta G, Carron PN.

Rev Med Suisse 2011;7:1574-1578.

Mood and non-mood components of perceived stress and exacerbation of Crohn’s disease.

Camara RJ, Schoepfer AM, Pittet V, Begré S, von Känel R, and the Swiss IBD cohort study group.

Inflamm Bowel Dis 2011;17:2358-2365.

Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.

Leblanc S, Allez M, Seksik P, Flourié B, Peeters H, Dupas JL, Bouguen G, Peyrin-Biroulet L, Duclos b, Bourreille A, Dewit O, Bouhnik Y, Michetti P, Chaussade S, Saussure P, Mary JY, Colombel JF, Lémann M.

Am J Gastroenterol 2011;106:771-777

Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B.

Farnik H, Lange CM, Hofmann WP, Berger A, Allwinn R, Welker MW, Trojan J, Sarrazin C, Herrmann E, Zeuzem S, Kronenberger B.

J Clin Virol 2011;52:204-209.

Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis.

Favre L, Borle F, Velin D, Bachmann D, Bouzourene H, Wagnières G, van den Bergh H, Ballabeni P, Gabrecht T, Michetti P, Schreiber S, Ortner MA.

Endoscopy 2011;43:604-616.

Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland [Letter].

Hruz P, Straumann A, Bussmann C, Heer P, Simon HU, Zwahlen M, Beglinger C, Schoepfer AM; Swiss EoE Study Group.

J Allergy Clin Immunol 2011;128:1349-1350.

Hepatitis E virus seroprevalence among blood donors in Southwest Switzerland.

Kaufmann A, Kenfak-Foguena A, André C, Canellini G, Bürgisser P, Moradpour D, Darling KEA, Cavassini M.

PLoS One 2011;6:e21150

Hepatitis E virus seroprevalence and chronic infection in HIV-infected patients with unexplained ALT elevation in the Swiss HIV Cohort Study.

Kenfak Foguena A, Schöni-Affolter F, Bürgisser P, Wittek A, Darling KEA, Kovari H, Kaiser L, Evison J-M, Elzi L, Gurtner-De La Fuente V, Jost J, Moradpour D, Abravanel F, Izopet J, Cavassini M, and the Swiss HIV Cohort Study.

Emerg Infect Dis 2011;17:1074-1078.

Impact of donor and recipient IL28Brs12979860 genotypes on hepatitis C virus liver graft reinfection.

Lange CM, Moradpour D, Doehring A, Lehr HA, Müllhaupt B, Bibert S, Bochud PY, Antonino AT, Pascual M, Farnik H, Shi Y, Bechstein WO, Moench C, Hansmann ML, Sarrazin C, Lötsch J, Zeuzem S, Hofmann WP.

J Hepatol 2011;55:322-327.

HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2a.

Lange CM, Susser S, Herrmann E, Karey U, Kieffer TL, Kwong AD, Schinkel J, Reesink HW, Zeuzem S, Sarrazin C.

Scand J Gastroenterol 2011,46:1362-8

Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sam

J Allergy Clin Immunol 2011:41:630-639.

PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.

Velin D, Narayan S, Bernasconi E, Busso N, Ramelli G, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Michetti P, So A.

Gastroenterology 2011;141:1273-1282.

Successful heart and liver transplantation in a Swiss patient with Glu89Lys transthyretin amyloidosis [Letter].

Niederhauser J, Lobrinus JA, Ochsner F, Wider C, Fellmann F, Yerly P, Antonino AT, Saraiva MJ, Moradpour D, Kuntzer T.

Transplantation 2011;91:e40-e42.

Development of the Crohn’s disease digestive damage score, the Lémann score.

Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Flechter JG, Chowers Y, D’Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV, Louis E, Michetti P, Munkholm P, Oresland T, Panés J, Peyrin-Biroulet L, Reinisch W, Sands BE, Schoelmeri

Inflamm Bowel Dis 2011:17:1415-1422.

NS4B self-interaction through conserved C-terminal elements is required for the establishment of functional hepatitis C virus replication complexes.

Paul D, Romero-Brey I, Gouttenoire J, Stoitsova S, Krijnse-Locker J, Moradpour D, Bartenschlager R.

J Virol 2011;85:6963-6976.

DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell responses in Intestinal Mucosa.

Perreau M, Welles HC, Harari A, Hall O, Martin R, Maillard M, Dorta G, Bart PA, Kremer EJ, Tartaglia J, Wagner R, Esteban M, Levy Y, Pantaleo G.

J Virol 2011;85:9854-9862.

NS2 protein of hepatitis C virus interacts with structural and nonstructural proteins towards virus assembly.

Popescu C-I, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, Duverlie G, Penin F, Héliot L, Rouillé Y, Dubuission J.

PLoS Pathog 2011;7:e1001278.

Placebo and other interventions in asthma [Letter].

Straumann A, Safroneeva E, Schoepfer AM.

N Engl J Med 2011;365:1446-1447.

Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

Straumann A, Conus S, Bussmann C, Degen L, Frei C, Beglinger C, Schoepfer AM, Simon HU.

Clin Gastroenterol Hepatol 2011;9:400-409.

Efficacy and safety of certolizumab pegol in an unselected Crohn’s disease population: 26 week data of the FACTS II survey.

Vavricka SR, Schoepfer AM, Bansky G, Binek J, Felley C, Geyer M, Manz M, Rogler G, de Saussure P, Sauter B, Scharl M, Seibold F, Straumann A, Michetti P, Swiss IBDnet.

Inflamm Bowel Dis 2011:17:1530-1539.

Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis?

Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, Brientini MP, Richou C, Minello A, Antonino AT, Gillet M, Ito A, Mantion GA, Vuitton DA.

A 20-year follow-up study. Liver Transpl 2011;17:855-865.

CHUV
Service de gastro-entérologie et
d'hépatologie
Rue du Bugnon 46
CH-1011 Lausanne
+41 21 314 4717

Impressum
Informations juridiques
Plan du site
Formulaire de contact

Dernière mise à jour le 01/05/2020 à 13:58

Publications

Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency survey.

[Fontan associated liver disease].

[Therapeutic endoscopic ultrasound: an innovative technique, revolutionizing our practice].

[Gastroesophageal reflux disease in 2024].

Cancer du pancréas : une épidémie oncologique en devenir ?

Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020.

Odynophagia and Retrosternal Pain Are Common in Eosinophilic Esophagitis and Associated with an Increased Overall Symptom Severity.

High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorder.

EUS-guided hepaticojejunostomy in patients with history of total gastrectomy: a multicenter retrospective feasibility study (with video).

Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.

Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Simultaneous combined transplantation: Intricacies in immunosuppression management.

[Colorectal cancer in 45-49-year-olds: systematic or targeted screening?].

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.

Long-Term Outcome of Surgery for Perianal Crohn's Fistula.

Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.

Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis.

A Hepatitis E Virus Infection Model in the Mongolian Gerbil: Ready for Antiviral and Vaccine Studies.

Direct oral anticoagulants in cirrhosis: Rationale and current evidence.

Functional results after hiatal repair and gastropexy without fundoplication in patients with paraoesophageal hernia.

Endoscopic Features of Eosinophilic Esophagitis.

A false positive hair ethylglucuronide dosage in an alcohol abstinent patient after liver transplantation: a case report.

Influence of Amino Acid Substitutions in Capsid Proteins of Coxsackievirus B5 on Free Chlorine and Thermal Inactivation.

EUS-BD for calibration of benign stenosis of the bile duct in patients with altered anatomy or inaccessible papilla.

A MULTICENTER LONG-TERM COHORT STUDY OF EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR PROGRESSION TO EOE OVER TIME.

Maladies inflammatoires chroniques de l’intestin chez les personnes âgées.

[Gastroenterology and hepatology: what's new in 2023].

Pediatric Patients with Eosinophilic Esophagitis and Their Parents Identify Symptoms as the Most Important Treatment Outcome.

A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication.

Eosinophil Distribution in Eosinophilic Esophagitis and its Impact on Disease Activity and Response to Treatment.

Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E.

A tridimensional atlas of the developing human head.

Endoscopic ultrasound-guided modification of surgical anatomy (from Roux-en-Y gastrectomy to Billroth II-like anatomy) for endoscopic treatment of malignant biliary stenosis.

Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology.

The high resolution absorption spectrum of methane in the 10 800-14 000 cm(-1) region: literature review, new results and perspectives.

First report of Xanthomonas campestris pv. campestris causing black rot on oilseed rape (Brassica napus L.) in France.

High-Pressure Delivery of Oncolytic Viruses via Needle-Free Injection Preserves Therapeutic Activity.

Anti-CMV therapy, what next? A systematic review.

Conditional knockout of REST/NRSF in excitatory neurons reduces seizure susceptibility to chemical kindling.

Neural alpha oscillations index context-driven perception of ambiguous vowel sequences.

Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.

Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis.

Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.

La maladie de Crohn.

Elevated liver function tests in a patient with breast cancer.

[siRNA therapeutics : Current options and perspectives].

[Functional dyspepsia : update 2023].

Hépatologie en 2023 : importance de la multidisciplinarité.

[Management of dysphagia].

Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.

An Unusual Cause of Severe Granulomatous Hepatitis and Jaundice.

[Management of acute cholecystitis].

Towards antivirals against hepatitis E: In the steps of hepatitis C.

The current and future burden of hepatitis B in Switzerland: a modelling study.

Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Urine: a place where HEV cannot hide!

Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure.

Efficacy and safety of endoscopic ultrasound guided drainage of pseudocysts and walled-off necrosis after failure of percutaneous drainage.

[Frequent Gastro-Intestinal Disorders: Management of Functional Dyspepsia and Irritable Bowel Syndrome in Clinical Practice].

Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes.

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study.

Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.

External validation and comparison of the Glasgow-Blatchford score, modified Glasgow-Blatchford score, Rockall score and AIMS65 score in patients with upper gastrointestinal bleeding: a cross-sectional observational study in Western Switzerland.

[Gastroenterology and hepatology: what's new in 2022].

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.

Immunohistochemistry for hepatitis E virus capsid protein cross-reacts with cytomegalovirus-infected cells: a potential diagnostic pitfall.

Marked weight loss on liraglutide 3.0 mg: Real-life experience of a Swiss cohort with obesity.

Drug-Related Adverse Events Necessitating Treatment Discontinuation in Pediatric Inflammatory Bowel Disease Patients.

The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients.

Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference.

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.

Hepatitis B reactivation during ruxolitinib treatment.

La résection endoscopique va-t-elle suppléer la chirugie ?

[Differential diagnosis and investigation of chronic diarrhea].

[Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology].

[Short telomere syndrome in adults: a rare entity that should be evoked].

Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic Esophagitis.

A novel case of biliary common bile duct reconstruction by the rendezvous technique using endoscopic cholangioscopy and percutaneous cholangioscopy.

<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.